{"SLR NAME":"Prevalence of positive SARS-CoV-2 recurrence in COVID-19 patients and its related characteristics: systematic review and meta-analysis","References":[{"title1":"Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test","References":[{"title2":"Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.World Health Organization.","References":[]},{"title2":"WHO characterizes COVID-19 as a pandemic. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen (accessed Mar 14, 2020).","References":[]},{"title2":"Clinical Characteristics of Coronavirus Disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","References":[]},{"title2":"Positive RT-PCR Test Results in Patients Recovered From COVID-19.","References":[{"title3":"Positive RT-PCR Test Results in Patients Recovered From COVID-19"},{"title3":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan"},{"title3":"Cause analysis and treatment strategies of recurrent positive nucleic acid test with Coronavirus disease 2019 (COVID-19) patients after discharge from hospital"},{"title3":"Efficacy of acupuncture at three nasal acupoints plus acupoint application for perennial allergic rhinitis: A multicenter, randomized controlled trial protocol"},{"title3":"To discuss the TCM prevention and treatment strategies of Coronavirus disease 2019 from the perspective of Cold-dampness plague"},{"title3":"Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: A Randomized Clinical Trial"},{"title3":"Effect of hot arm and foot bath on heart rate variability and blood pressure in healthy volunteers"},{"title3":"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis"},{"title3":"Two Cases of Improving Positive results of nucleic acid test in Coronavirus disease 2019 (COVID-19) by induced sputum with atomization inhalation"},{"title3":"The effect of Baduanjin exercise on health-related physical fitness of college students: study protocol for a randomized controlled trial"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A Review Study on the Beneficial Effects of Baduanjin"}]},{"title2":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Text Transcription of Press Conference on February 11, 2020 (in Chinese)"},{"title3":"Transmissibility of 2019-nCoV"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection is Suspected"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Positive result of SARS-Co-2 in sputum from a cured patient with COVID-19.","References":[]},{"title2":"Wei Fu, Qian Chen, and Tao Wang. Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies. J Med Virol 2020. [Epub ahead of print].","References":[]},{"title2":"Available online: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml (accessed Mar 9, 2020).","References":[]},{"title2":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.","References":[{"title3":"Clinical and immunological characteristics of human infections with H5N6 avian influenza virus"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure"},{"title3":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology"},{"title3":"Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease"},{"title3":"The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Effects of calcium channel blockers comparing to angiotensinconverting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumoniarelated outcomes"},{"title3":"An expanded definition of the adult respiratory distress syndrome"},{"title3":"A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice"},{"title3":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure"},{"title3":"Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases Wuhan, China 2019-2020"},{"title3":"Angiotensin blockade in late autosomal dominant polycystic kidney disease"},{"title3":"Hypoalbuminemia in acute illness: is there a rationale for intervention?"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse"},{"title3":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"}]},{"title2":"Wei L, Ming SQ, Zou B, et al. Viral Invasion and Type I Interferon Response Characterize the Immunophenotypes during Covid-19 Infection. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3555695","References":[]},{"title2":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome.","References":[]},{"title2":"False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus.","References":[{"title3":"A novel Coronavirus from patients with pneumonia in China, 2019"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing"},{"title3":"CT imaging features of 2019 novel Coronavirus (2019-nCoV)"}]},{"title2":"Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection SARS-CoV-2 through conjunctiva.","References":[]},{"title2":"Zhang F, Abudayyeh OO, Gootenberg JS. A protocol for detection of COVID-19 using CRISPR diagnostics (v.20200321). Available online: https://www.broadinstitute.org/files/publications/special/COVID-19%20detection%20(updated).pdf","References":[]},{"title2":"Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.","References":[{"title3":"Rigidity of the outer shell predicted by a protein intrinsic disorder model sheds light on the COVID-19 (Wuhan-2019-nCoV) infectivity"},{"title3":"Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?"},{"title3":"A novel coronavirus emerging in China - key questions for impact assessment"},{"title3":"Presumed asymptomatic carrier transmission of COVID-19"}]}]},{"title1":"Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance.","References":[]},{"title2":"Novel Coronavirus (2019-nCoV)","References":[{"title3":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence"},{"title3":"Impact of COVID-19 on Canadians"},{"title3":"A brief measure for assessing generalized anxiety disorder: the GAD-7"},{"title3":"Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis"},{"title3":"Psychological and behavioral impact of lockdown and quarantine measures for COVID-19 pandemic on children, adolescents and caregivers: a systematic review and meta-analysis"},{"title3":"Assessing the influence of parental anxiety on childhood anxiety during the COVID-19 pandemic in the United Arab Emirates"},{"title3":"Anxiety and depression symptoms, and lack of emotional support among the general population before and during the COVID-19 Pandemic. A prospective national study on prevalence and risk factors"},{"title3":"Initial challenges of caregiving during COVID-19: caregiver burden, mental health, and the parent-child relationship"},{"title3":"Well-being of parents and children during the COVID-19 Pandemic: a national survey"},{"title3":"The impact of COVID-19 on children with autism spectrum disorder"},{"title3":"Psychiatric disorders in children and adolescents during the COVID-19 pandemic"},{"title3":"Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak"},{"title3":"Post-secondary maternal education buffers against neural risk for psychological vulnerability to future life stress"},{"title3":"Clinical and psychological effects of excessive screen time on children"},{"title3":"Obesity and activity patterns before and during COVID-19 lockdown among youths in China"},{"title3":"Screen time for children and adolescents during the coronavirus disease 2019 pandemic"},{"title3":"COVID-19-related weight gain in school-aged children"},{"title3":"Obesity in children and adolescents during COVID-19 pandemic"},{"title3":"Weight gain in children during the covid-19 quarantine period"},{"title3":"SARS pandemic exposure impaired early childhood development: a lesson for COVID-19"},{"title3":"Increased screen time: implications for early childhood development and behavior"},{"title3":"Relationship between parenting practices and children's screen time during the COVID-19 pandemic in Turkey"},{"title3":"Applying harm reduction principles to address screen time in young children amidst the COVID-19 Pandemic"},{"title3":"Screen time young and children: promoting health and development in a digital world"},{"title3":"Influencing factors of screen time in preschool children: an exploration of parents' perceptions through focus groups in six European countries"},{"title3":"British families in lockdown: initial findings"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"The proximal origin of SARS-CoV-2.","References":[{"title3":"The proximal origin of SARS-CoV-2"},{"title3":"An update on the origin of SARS-CoV-2: despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues [published online ahead of print July 07, 2020]"},{"title3":"Molecular evolution of human coronavirus genomes"},{"title3":"Coronavirus spike protein and tropism changes"},{"title3":"Receptor recognition mechanisms of coronaviruses: a decade of structural studies"},{"title3":"The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance"},{"title3":"Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection"},{"title3":"High-frequency RNA recombination of murine coronaviruses"},{"title3":"Distinct viral clades of SARS-CoV-2: implications for modeling of viral spread [published online ahead of print April 20, 2020]"}]},{"title2":"Phylogenetic network analysis of SARS-CoV-2 genomes.","References":[{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"Ice Ages and the mitochondrial DNA chronology of human dispersals: A review"},{"title3":"Evolution. Mother tongue and Y chromosomes"},{"title3":"Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary"},{"title3":"A systematic review of COVID-19 epidemiology based on current evidence"},{"title3":"Evolving COVID-19 conundrum and its impact"},{"title3":"Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable"}]},{"title2":"Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.","References":[{"title3":"Distribution of Chinese and global COVID-19 outbreak daily updated by China CDC"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing"},{"title3":"Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion"},{"title3":"Understanding the influencing factors of nucleic acid detection of 2019 novel coronavirus"}]},{"title2":"Chinese management guideline for COVID-19 (version 6.0).","References":[]},{"title2":"Positive RT-PCR test results in patients recovered from COVID-19.","References":[{"title3":"Positive RT-PCR Test Results in Patients Recovered From COVID-19"},{"title3":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan"},{"title3":"Cause analysis and treatment strategies of recurrent positive nucleic acid test with Coronavirus disease 2019 (COVID-19) patients after discharge from hospital"},{"title3":"Efficacy of acupuncture at three nasal acupoints plus acupoint application for perennial allergic rhinitis: A multicenter, randomized controlled trial protocol"},{"title3":"To discuss the TCM prevention and treatment strategies of Coronavirus disease 2019 from the perspective of Cold-dampness plague"},{"title3":"Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: A Randomized Clinical Trial"},{"title3":"Effect of hot arm and foot bath on heart rate variability and blood pressure in healthy volunteers"},{"title3":"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis"},{"title3":"Two Cases of Improving Positive results of nucleic acid test in Coronavirus disease 2019 (COVID-19) by induced sputum with atomization inhalation"},{"title3":"The effect of Baduanjin exercise on health-related physical fitness of college students: study protocol for a randomized controlled trial"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A Review Study on the Beneficial Effects of Baduanjin"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in hubei (epicentre) and outside hubei (non-epicentre): a nationwide analysis of China.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"COVID-19 in a designated infectious diseases hospital outside Hubei Province, China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Sequential emergence and wide spread of nutralization escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015"},{"title3":"Transmission dynamics and evolutionary history of 2019-nCoV"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","References":[]},{"title2":"Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report.","References":[{"title3":"COVID-19 cases worldwide. Available from: https://www.worldometers.info/coronavirus/. Accessed 30 Apr 2020"},{"title3":"Systemic lupus erythematosus"},{"title3":"Global natural regulatory T cell depletion in active systemic lupus erythematosus"},{"title3":"Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus"},{"title3":"Katsuyama E, Suarez-Fueyo A, Bradley SJ, Mizui M, Marin AV, Mulki L et al (2020) The CD38/NAD/SIRTUIN1/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep 30(1)"},{"title3":"Gordon C, Amissah-Arthur M-B, Gayed M, Brown S, Bruce IN, D'Cruz D et al (2018) The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford) 57(1)"},{"title3":"Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients"},{"title3":"Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, Ogdie A, Katz P (2020) Experiences of patients with rheumatic diseases in the US during early days of the COVID-19 pandemic. ACR Open Rheumatol"},{"title3":"Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JIP, Potential Rapid Diagnostics et al Vaccine and Therapeutics for 2019 Novel coronavirus (2019-nCoV): a systematic review. J Clin Med 2020, 9(3)"},{"title3":"Zhu L, Xu X, Ma K, Yang J, Guan H, Chen S, Chen Z, Chen G (2020) Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant"},{"title3":"Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF et al (2020) On the alert for cytokine storm: Immunopathology in COVID-19. Arthritis &amp; rheumatology (Hoboken, NJ)"},{"title3":"Effects of chloroquine on viral infections: an old drug against today's diseases?"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"(2020) Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 43(3):185-188"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol"},{"title3":"FDA Issues FAQs on Emergency Use Authorization for Hydroxychloroquine and Chloroquine. Available from: https://www.rheumatology.org/Portals/0/Files/FAQs-EUA-Chloroquine-Phosophate-Hydroxychloroquine-Sulfate-Certain-COVID-19-Patients.pdf. Accessed 27 Apr 2020"},{"title3":"Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know"},{"title3":"EULAR guidance for patients during Covid-19 outbreak. Mar 17, 2020. Available from: https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm. Accessed 27 Apr 2020"},{"title3":"BSR guidance for patients during Covid-19 outbreak. Apr 23, 2020. Available from: https://www.rheumatology.org.uk/News-Policy/Details/Covid19-Coronavirus-update-members. Accessed 27 Apr 2020"},{"title3":"Australian Rheumatology Association guidance for patients during Covid-19 outbreak. Mar 17, 2020. Available from: https://arthritisaustralia.com.au/advice-regarding-coronavirus-covid-19-from-the-australian-rheumatology-association/. Accessed 27 Apr 2020"},{"title3":"ACR guidance for patients during Covid-19 outbreak. Apr 14, 2020. Available from: https://www.rheumatology.org/announcements. Accessed 27 Apr 2020"},{"title3":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y et al (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia"},{"title3":"Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"National Health Commission of the People's Republic of China. Chinese diagnosis and treatment guideline for COVID-19 (version 6.0). Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817. Accessed 27 Apr 2020"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"}]},{"title2":"PCR assays turned positive in 25 discharged COVID-19 patients.","References":[]},{"title2":"Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China.","References":[]},{"title2":"The duration of viral shedding of discharged patients with severe COVID-19.","References":[]},{"title2":"Factors associated with prolonged viral RNA shedding in patients with COVID-19.","References":[{"title3":"Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study"},{"title3":"Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in coronavirus disease 2019: a case control study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Viral load of SARS-CoV-2 in clinical samples"},{"title3":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients"},{"title3":"Factors associated with prolonged viral RNA shedding in patients with COVID-19 [published online ahead of print April 9, 2020]"},{"title3":"Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"},{"title3":"Prolonged presence of SARS-CoV-2 viral RNA in faecal samples"}]},{"title2":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"ACE2: from vasopeptidase to SARS virus receptor"},{"title3":"Novel Coronavirus Pneumonia Emergency Response Epidemiology. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan"},{"title3":"[A pathological report of three COVID-19 cases by minimally invasive autopsies]"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Current concepts in the diagnosis and management of cytokine release syndrome"},{"title3":"Plcgamma2/Tmem178 dependent pathway in myeloid cells modulates the pathogenesis of cytokine storm syndrome"},{"title3":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"High-volume haemofiltration for sepsis in adults"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"The cytokine storm of severe influenza and development of immunomodulatory therapy"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Targeting the IL-6/JAK/STAT3 signalling axis in cancer"},{"title3":"Immunotherapeutic implications of IL-6 blockade for cytokine storm"},{"title3":"Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock"},{"title3":"[Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies]"},{"title3":"CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19"},{"title3":"Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome"},{"title3":"Cytokine release syndrome"},{"title3":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells"},{"title3":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis"},{"title3":"Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial"},{"title3":"Interleukin 6 receptor inhibitor tocilizumab suppresses cytokine expression, inflammasome activation and phagocytosis in a cell model of sepsis"},{"title3":"Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)"},{"title3":"New therapeutic opportunities for COVID-19 patients with Tocilizumab: possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws"},{"title3":"Cytotoxic therapy for severe avian influenza A (H5N1) infection"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Polybacterial stimulation suggests discrete IL-6/IL-6R signaling in human fetal membranes: potential implications on IL-6 bioactivity"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in wuhan, China"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis"},{"title3":"Tocilizumab as an adjuvant therapy for hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis"},{"title3":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome"},{"title3":"Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy"},{"title3":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients"},{"title3":"T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade"},{"title3":"Safe usage of anakinra and dexamethasone to treat refractory hemophagocytic lymphohistiocytosis secondary to acute disseminated histoplasmosis in a patient with HIV/AIDS"},{"title3":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis"},{"title3":"Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab"},{"title3":"Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis"},{"title3":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens"},{"title3":"Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus"},{"title3":"Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial"},{"title3":"Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus"},{"title3":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab"},{"title3":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study"},{"title3":"CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-gamma pathway"},{"title3":"Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib"},{"title3":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition"},{"title3":"Emapalumab: first global approval"},{"title3":"Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis"},{"title3":"Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats"},{"title3":"Safety and efficacy of infliximab therapy in the setting of steroid-refractory acute graft-versus-host disease"},{"title3":"Critical imbalance of TNF-alpha and soluble TNF receptor 1 in a patient with macrophage activation syndrome: potential implications for diagnostics and treatment"},{"title3":"Combination therapy for graft-versus-host disease prophylaxis with etanercept and extracorporeal photopheresis: results of a phase II clinical trial"},{"title3":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia"},{"title3":"Ponatinib protects mice from lethal influenza infection by suppressing cytokine storm"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes"},{"title3":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis"},{"title3":"Therapy improves acute respiratory distress syndrome in mice"},{"title3":"Cyclosporin A inhibits the replication of diverse coronaviruses"},{"title3":"Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis"},{"title3":"Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection"},{"title3":"Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study"},{"title3":"Early introduction of peritoneal dialysis may improve survival in severe sepsis"},{"title3":"Effects of hemodialysis and hemoperfusion on inflammatory factors and nuclear transcription factors in peripheral blood cell of multiple organ dysfunction syndrome"},{"title3":"Rescue of cytokine storm due to HLH by hemoadsorption in a CTLA4-deficient patient"},{"title3":"Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS"},{"title3":"Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity"},{"title3":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study"},{"title3":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial"},{"title3":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients"},{"title3":"A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis"},{"title3":"Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury"},{"title3":"Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment"}]},{"title2":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients.","References":[]},{"title2":"Clinical and immunological features of severe and moderate coronavirus disease 2019.","References":[]},{"title2":"Analysis of serum cytokines in patients with severe acute respiratory syndrome.","References":[]},{"title2":"Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China.","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management.","References":[]},{"title2":"The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics.","References":[]},{"title2":"CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China.","References":[]},{"title2":"Radiographic and CT features of viral pneumonia.","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Radiographic and CT features of viral pneumonia"},{"title3":"Emerging 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases"},{"title3":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society"},{"title3":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma"}]},{"title2":"Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis.","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020"},{"title3":"High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Detection of SARS coronavirus in patients with suspected SARS"},{"title3":"WHO issues consensus document on the epidemiology of SARS"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"},{"title3":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America"},{"title3":"Quantifying heterogeneity in a meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Epidemiological characteristics of novel coronavirus pneumonia in Henan"},{"title3":"Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study"},{"title3":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China"},{"title3":"Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. In press."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV"},{"title3":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2"},{"title3":"The clinical and chest CT features associated with severe and critical COVID-19 pneumonia"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. In press."},{"title3":"Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features"},{"title3":"Clinical characteristics and treatment strategies of 79 patients with COVID-19"},{"title3":"Evidence for gastrointestinal infection of SARS-CoV-2"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2"},{"title3":"Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin"},{"title3":"Huang Y, Tu M, Wang S, et al. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single center analysis. Travel Med Infect Dis. In press."},{"title3":"Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia"},{"title3":"Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China"},{"title3":"Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol. In press."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China"},{"title3":"Clinical and chest HRCT characteristics in family group outbreak of novel coronavirus pneumonia"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia presented gastrointestinal symptoms but without fever onset. Preprints with The Lancet"},{"title3":"Epidemiological analysis on a family cluster of COVID-19"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment"},{"title3":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period"},{"title3":"Three cases of novel coronavirus pneumonia with viral nucleic acids still positive in stool after throat swab detection turned negative"},{"title3":"2019 novel coronavirus disease (COVID-19) in Taiwan: reports of two cases from Wuhan, China"},{"title3":"First case of coronavirus disease 2019 (COVID-19) pneumonia in Taiwan"},{"title3":"Shu ru xing nan bian xing xin xing guan zhuang bing du fei yan yi li ji chuan bo mo shi fen xi"},{"title3":"The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019"},{"title3":"SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19"},{"title3":"The treatment and outcome of a lung cancer patient infected with SARS-CoV-2"},{"title3":"Biological characters analysis of COVID-19 patient accompanied with aplastic anemia"},{"title3":"Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease"},{"title3":"Early epidemiological and clinical characteristics of 28 cases of coronavirus disease in South Korea"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea"},{"title3":"Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Covert COVID-19 and false-positive dengue serology in Singapore"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China"},{"title3":"Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults"},{"title3":"Cai J, Xu J, Lin D, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. In press."},{"title3":"First case of severe childhood novel coronavirus pneumonia in China"},{"title3":"First case of neonate infected with novel coronavirus pneumonia in China"},{"title3":"2019-novel coronavirus infection in a three-month-old baby"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia"},{"title3":"Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases"},{"title3":"Diagnosis and treatment of novel coronavirus pneumonia in pregnancy with gastrointestinal symptoms as first manifestations"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital of the Chinese People's Liberation Army"}]},{"title2":"Acute respiratory distress syndrome: the berlin definition.","References":[]},{"title2":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury.","References":[]}]},{"title1":"Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19)","References":[{"title2":"Emergence of a novel coronavirus causing respiratory illness from Wuhan. China","References":[{"title3":"A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia"},{"title3":"SARS Guidelines Committee of the British Thoracic Society; British Infection Society; Health Protection Agency. Hospital management of adults with severe acute respiratory syndrome (SARS) if SARS re-emerges-updated 10 February 2004"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"WHO. Novel coronavirus - Thailand (ex-China). Disease outbreak news. 14 January 2020. https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand-ex-china/en/"},{"title3":"ProMed Mail. Novel coronavirus (07): China (HU), Thailand ex China, Japan ex China, WHO. 2020. Archive Number: 20200117.6895647."},{"title3":"WHO. Update information on Thailand responding to the novel coronavirus. 17 January 2020. https://www.who.int/thailand/news/detail/17-01-2020-update-information-on-thailand-responding-to-the-novel-coronavirus"},{"title3":"WHO. Novel coronavirus - Japan (ex-China). disease outbreak news. 17 January 2020. https://www.who.int/csr/don/17-january-2020-novel-coronavirus-japan-ex-china/en/"},{"title3":"Ferguson N.Imperial College London, UK. 17 January 2020. https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news-wuhan-coronavirus/"}]},{"title2":"World Health Organization. Novel coronavirus (2019-nCoV). Situation Report:48https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A decade after SARS: strategies for controlling emerging coronaviruses","References":[{"title3":"Management and prevention of SARS in China"},{"title3":"Severe acute respiratory syndrome"},{"title3":"The chronology of the 2002-2003 SARS mini pandemic"},{"title3":"Coronaviruses in bats from Mexico"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus Deltacoronavirus supports bat coronaviruses as the gene source of Alphacoronavirus and Betacoronavirus and avian coronaviruses as the gene source of Gammacoronavirus and Deltacoronavirus"},{"title3":"Recent transmission of a novel Alphacoronavirus, bat coronavirus HKU10, from Leschenault's rousettes to pomona leaf-nosed bats: first evidence of interspecies transmission of coronavirus between bats of different suborders"},{"title3":"Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana"},{"title3":"Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Prevalence and genetic diversity of coronaviruses in bats from China"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread"},{"title3":"Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge"},{"title3":"Identification of new human coronaviruses"},{"title3":"The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A review of studies on animal reservoirs of the SARS coronavirus"},{"title3":"Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Identification of a new human coronavirus"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Coronavirus infection and hospitalizations for acute respiratory illness in young children"},{"title3":"A case for the ancient origin of coronaviruses"},{"title3":"Evidence supporting a zoonotic origin of human coronavirus strain NL63"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Efficient replication of the novel human Betacoronavirus EMC on primary human epithelium highlights its zoonotic potential"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Cotten, M. et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet10.1016/S0140-6736(13)61887-5 (2013)."},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Retrospective serological investigation of severe acute respiratory syndrome coronavirus antibodies in recruits from mainland China"},{"title3":"SARS-related virus predating SARS outbreak, Hong Kong"},{"title3":"Bats and their virome: an important source of emerging viruses capable of infecting humans"},{"title3":"Review of bats and SARS"},{"title3":"Urban habituation, ecological connectivity and epidemic dampening: the emergence of Hendra virus from flying foxes (Pteropus spp.)"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Detection and phylogenetic analysis of group 1 coronaviruses in South American bats"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of Pipistrellus bat coronavirus HKU5 in Japanese Pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus"},{"title3":"Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1"},{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"An immunosuppressed Syrian golden hamster model for SARS-CoV infection"},{"title3":"Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing Fab'2"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters"},{"title3":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets"},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"SARS vaccines: where are we?"},{"title3":"Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines"},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus"},{"title3":"Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells"},{"title3":"Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques"},{"title3":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African green, rhesus and cynomolgus monkeys"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice"},{"title3":"A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice"},{"title3":"Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry"},{"title3":"Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease"},{"title3":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549)"},{"title3":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine"},{"title3":"Engineering attenuated virus vaccines by controlling replication fidelity"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease"},{"title3":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein"},{"title3":"Discovery of an RNA virus 3' 5' exoribonuclease that is critically involved in coronavirus RNA synthesis"},{"title3":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genome"},{"title3":"Scobey, T. et al. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc. Natl Acad. Sci. USA (2013). This paper describes the design and implementation of an infectious cDNA clone of MERS-CoV."},{"title3":"Engineering a replication-competent, propagation-defective middle East respiratory syndrome coronavirus as a vaccine candidate"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"SARS coronavirus vaccine development"},{"title3":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region"},{"title3":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice"},{"title3":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS"},{"title3":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity"},{"title3":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies"},{"title3":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine"},{"title3":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein"},{"title3":"Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates"},{"title3":"SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens"},{"title3":"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines"},{"title3":"Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine"},{"title3":"Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus"},{"title3":"A strategy to estimate unknown viral diversity in mammals"},{"title3":"A new coronavirus-like particle associated with diarrhea in swine"},{"title3":"Aetiology of diarrhoea in young calves"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"SARS coronavirus accessory proteins"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein"},{"title3":"Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43"},{"title3":"Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines"},{"title3":"Persistent infection promotes cross-species transmissibility of mouse hepatitis virus"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Virus-induced acute respiratory distress syndrome: epidemiology, management and outcome"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Acute lung injury review"},{"title3":"Long-term outcome of acute respiratory distress syndrome caused by severe acute respiratory syndrome (SARS): an observational study"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission"},{"title3":"Ge, X.-Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature10.1038/nature12711 (2013)."}]},{"title2":"Cumulative number of reported cases of 2019 novel coronavirus pneumonia. Beijing: National health commission of the People's Republic of China,2020[EB/OL]. [2020-02-29]. http://www.nhc.gov.cn/xcs/yqfkdt/202002/4ef8b5221b4d4740bda3145ac37e68ed.shtml","References":[]}]},{"title1":"Predictive diagnosis of chronic obstructive pulmonary disease using serum metabolic biomarkers and least?squares support vector machine","References":[{"title2":"COPD guidelines: a review of the 2018 GOLD report","References":[]},{"title2":"Global and regional trends in COPD mortality, 1990-2010","References":[{"title3":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010"},{"title3":"Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study"},{"title3":"An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease"},{"title3":"Childhood respiratory infection and adult chronic bronchitis in England and Wales"},{"title3":"Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease"},{"title3":"Chronic Obstructive Pulmonary Disease Mortality and Prevalence: the associations with smoking and poverty - a BOLD analysis"},{"title3":"Diseases of the Respiratory System"},{"title3":"Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity and smoking"},{"title3":"Chronic obstructive pulmonary disease: current burden and future projections"},{"title3":"Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific"},{"title3":"100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption"},{"title3":"Forecasts of COPD mortalty in Australia:2006-2025"},{"title3":"Age-Period-Cohort Analysis of Chronic Obstructive Pulmonary Disease Mortality in Japan, 1950-2004"},{"title3":"Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis"},{"title3":"Algorithms for enhancing public health utility of national causes-of-death data"},{"title3":"Mortality from tobacco in developed countries: indirect estimation from national vital statistics"},{"title3":"Using the margins command to estimate and interpret adjusted predictions and marginal effects"},{"title3":"Estimates of global mortality attributable to smoking in 2000"},{"title3":"Forced vital capacity, airway obstruction and survival in a general population sample from the USA"},{"title3":"The use of ethnically specific norms for ventilatory function in African-American and white populations"},{"title3":"Association of birth weight with adult lung function: findings from the British Women's Heart and Health Study and a meta-analysis. [Review] [40 refs]"},{"title3":"Birth weight and lung function in a cohort of Chinese school children"},{"title3":"Early growth and adult respiratory function in men and women followed from the fetal period to adulthood"},{"title3":"Low birth weight and lung function in adulthood: retrospective cohort study in china, 1948-1996"},{"title3":"The relationship between pneumonia in early childhood and impaired lung function in late adult life"},{"title3":"Socioeconomic disparities in pregnancy outcome: why do the poor fare so poorly?"},{"title3":"Pneumonia and poverty: a prospective population-based study among children in Brazil"}]},{"title2":"Global burden of COPD","References":[{"title3":"Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017"},{"title3":"Global and regional estimates of COPD prevalence: systematic review and meta-analysis"},{"title3":"Trends and patterns of differences in chronic respiratory disease mortality among US counties, 1980-2014"},{"title3":"Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study"},{"title3":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017"},{"title3":"Prevalence of chronic obstructive pulmonary disease (COPD) in China in 1990 and 2010"},{"title3":"Chronic obstructive pulmonary disease in China: a nationwide prevalence study"},{"title3":"Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey"},{"title3":"Underestimation of airflow obstruction among young adults using FEV1/FVC &lt; 70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes"},{"title3":"The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: a systematic analysis for the global burden of disease study"},{"title3":"The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017"},{"title3":"The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017"},{"title3":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019"},{"title3":"Global burden of COPD"},{"title3":"Early appraisal of China's huge and complex health-care reforms"},{"title3":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016"},{"title3":"Aging tsunami coming: the main finding from China's seventh national population census"},{"title3":"in China: the burden and importance of proper management"},{"title3":"Socioeconomic variations in chronic obstructive pulmonary disease prevalence, diagnosis, and treatment in rural Southwest China"},{"title3":"A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013: findings from the global burden of disease study 2013"},{"title3":"Associations between BODE index and systemic inflammatory biomarkers in COPD"},{"title3":"Impact of education on COPD severity and all-cause mortality in lifetime never-smokers and longtime ex-smokers: results of the COSYCONET Cohort"},{"title3":"Predicting and preventing hospital readmission for exacerbations of COPD"},{"title3":"Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the global burden of disease study 2017"},{"title3":"Global burden of respiratory diseases attributable to ambient particulate matter pollution: findings from the global burden of disease study 2019"},{"title3":"Cigarette smoke induced lung barrier dysfunction, EMT, and tissue remodeling: a possible link between COPD and lung cancer"},{"title3":"Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1/2 pathway"},{"title3":"Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries"},{"title3":"Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data"},{"title3":"Ambient air pollution, climate change, and population health in China"},{"title3":"The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990-2017: an analysis for the global burden of disease study 2017"},{"title3":"and gender differences: an update"},{"title3":"Disease burden of COPD in China: a systematic review"},{"title3":"Global burden of COPD attributable to ambient PM2.5 in 204 countries and territories, 1990 to 2019: a systematic analysis for the global burden of disease study 2019"}]},{"title2":"Under-and over-diagnosis of COPD: a global perspective","References":[{"title3":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010"},{"title3":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010"},{"title3":"Chronic obstructive pulmonary disease in non-smokers"},{"title3":"An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease"},{"title3":"Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction"},{"title3":"Factors associated with undiagnosed and overdiagnosed COPD"},{"title3":"Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease"},{"title3":"Diagnostic instability and reversals of chronic obstructive pulmonary disease diagnosis in individuals with mild to moderate airflow obstruction"},{"title3":"Global burden of COPD: systematic review and meta-analysis"},{"title3":"Association of lung function and chronic obstructive pulmonary disease with American Heart Association's Life's Simple 7 cardiovascular health metrics"},{"title3":"Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994"},{"title3":"Estimating the US prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010"},{"title3":"International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study"},{"title3":"Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease"},{"title3":"Health services burden of undiagnosed and overdiagnosed COPD"},{"title3":"COPD in the general population: prevalence, incidence and survival"},{"title3":"COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study"},{"title3":"Prevalence of COPD in Copenhagen"},{"title3":"Praevalensen af kronisk obstruktiv lungesygdom - sekundaerpublikation. [Prevalence of chronic obstructive pulmonary disease - secondary publication]"},{"title3":"Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study"},{"title3":"The prevalence of asthma and COPD in Italy: a practice-based study"},{"title3":"The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden - the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study"},{"title3":"Reported prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation"},{"title3":"The health impact of undiagnosed airflow obstruction in a national sample of United States adults"},{"title3":"Undiagnosed obstructive lung disease in the United States. Associated factors and long-term mortality"},{"title3":"Interpreting COPD prevalence estimates: what is the true burden of disease?"},{"title3":"Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD Study"},{"title3":"Estimating the prevalence of COPD in Canada: reported diagnosis versus measured airflow obstruction"},{"title3":"The diagnostic performance of patient symptoms in screening for COPD"},{"title3":"Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population"},{"title3":"Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, Russia"},{"title3":"Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits"},{"title3":"Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers"},{"title3":"Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort"},{"title3":"Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities"},{"title3":"Prevalence of airflow obstruction in smokers and never-smokers in Switzerland"},{"title3":"Chronic obstructive pulmonary disease in Finland: prevalence and risk factors"},{"title3":"Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies"},{"title3":"Prevalence of airways obstruction in a general population: European Respiratory Society versus American Thoracic Society definition"},{"title3":"Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care"},{"title3":"Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population"},{"title3":"The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD"},{"title3":"Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more"},{"title3":"Factors associated with misdiagnosis of COPD in primary care"},{"title3":"Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice"},{"title3":"Quantifying health services use for chronic obstructive pulmonary disease"},{"title3":"Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study"},{"title3":"Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation"},{"title3":"Necropsy incidence of emphysema in Uganda"},{"title3":"Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study"},{"title3":"Chronic airflow obstruction in a black African population: results of BOLD Study, Ile-Ife, Nigeria"},{"title3":"Noncommunicable lung disease in Sub-Saharan Africa. A community-based cross-sectional study of adults in urban Malawi"},{"title3":"Wood smoke exposure, poverty and impaired lung function in Malawian adults"},{"title3":"Effects of cooking fuel smoke on respiratory symptoms and lung function in semi-rural women in Cameroon"},{"title3":"The burden and impact of COPD in Asia and Africa"},{"title3":"Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda"},{"title3":"Chronic respiratory disease among the elderly in South Africa: any association with proximity to mine dumps?"},{"title3":"Prevalence and determinants of chronic obstructive pulmonary disease in HIV infected patients in an African country with low level of tobacco smoking"},{"title3":"Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study"},{"title3":"Tuberculosis associated chronic obstructive pulmonary disease"},{"title3":"The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities"},{"title3":"Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru"},{"title3":"Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population"},{"title3":"Underdiagnosis of COPD at primary health care clinics in the city of Aparecida de Goiania, Brazil"},{"title3":"Comparative study of respiratory symptoms and lung function alterations in patients with chronic obstructive pulmonary disease related to the exposure to wood and tobacco smoke"},{"title3":"COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women"},{"title3":"Effect of biomass smoke on chronic obstructive pulmonary disease in rural localities of Colombia"},{"title3":"Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults"},{"title3":"Occupational and biomass exposure in chronic obstructive pulmonary disease: results of a cross-sectional analysis of the On-Sint Study"},{"title3":"Respiratory manifestations and respiratory diseases: prevalence and risk factors among pig farmers in Braco do Norte, Brazil"},{"title3":"Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China"},{"title3":"Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China"},{"title3":"Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey"},{"title3":"Regional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB)"},{"title3":"Chronic obstructive pulmonary disease in China: a nationwide prevalence study"},{"title3":"COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model"},{"title3":"Determinants of respiratory symptom development in patients with chronic airflow obstruction"},{"title3":"Prevalence of COPD in Abu Dhabi, United Arab Emirates"},{"title3":"Prevalence of chronic bronchitis in an industrial population in North India"},{"title3":"A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure"},{"title3":"Prevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustion"},{"title3":"Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH)"},{"title3":"Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty - a BOLD analysis"},{"title3":"The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016"},{"title3":"Prevalence and determinants of chronic obstructive pulmonary disease (COPD) in Bangladesh"},{"title3":"The prevalence of chronic obstructive pulmonary disease and the determinants of underdiagnosis in women exposed to biomass fuel in India - a cross section study"},{"title3":"Worldwide burden of COPD in high- and low-income countries. Part I. The Burden of Obstructive Lung Disease (BOLD) initiative"},{"title3":"Urbanization and daily exposure to biomass fuel smoke both contribute to chronic bronchitis risk in a population with low prevalence of daily tobacco smoking"}]},{"title2":"The systemic nature of mustard lung: comparison with COPD patients","References":[{"title3":"The pathogenesis of bleomycin-induced pulmonary fibrosis in mice"},{"title3":"Comparison of prevalence of osteoporosis in patients with asthma following chemical injury in patients with asthma Sulfur-mustard non chemical victims"},{"title3":"COPD as a systemic disease"},{"title3":"Analysis of systemic biomarkers in COPD patients"},{"title3":"COPD, asthma and C-reactive protein"},{"title3":"Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases"},{"title3":"Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease"},{"title3":"Delayed toxic effects of sulfur mustard on respiratory tract of Iranian veterans"},{"title3":"Systemic manifestations and comorbidities of COPD"},{"title3":"The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis"},{"title3":"Nuclear factor-kappaB: a key regulator in health and disease of lungs"},{"title3":"Comparing the bone mineral density in chemical injures and non-chemical asmatic patients"},{"title3":"COPD and osteoporosis"},{"title3":"The role of nuclear factor-kappa B in cytokine gene regulation"},{"title3":"Overview and history of chemokines and their receptors"},{"title3":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease"},{"title3":"The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease"},{"title3":"Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response"},{"title3":"Antioxidant responses to oxidant-mediated lung diseases"},{"title3":"Markers of early disease and prognosis in COPD"},{"title3":"C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease"},{"title3":"The effect of sulfur mustard gas (SMG) on the immune system"},{"title3":"Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD"},{"title3":"NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival"},{"title3":"New functions for the matrix metalloproteinases in cancer progression"},{"title3":"Inhalation of alkylating mustard causes long-term T cell-dependent inflammation in airways and growth of connective tissue"},{"title3":"Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis"},{"title3":"Regular review: chemical weapons"},{"title3":"Does Sulfur Mustard (HD) have an accelerating effect on CABG in HD-exposed people? Is it a link?"},{"title3":"Mustard lung anesthesia; general anesthesia for patients with chronic obstructive pulmonary disease due to sulphur mustard exposure"},{"title3":"Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung"},{"title3":"Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases"},{"title3":"Inspiratory muscle training in adults with chronic obstructive pulmonary disease: a systematic review"},{"title3":"Late respiratory effects of sulfur mustard: how is the early symptoms severity involved?"},{"title3":"Long term consequences from exposure to sulfur mustard: a review"},{"title3":"Long-term ocular complications of sulfur mustard in the civilian victims of Sardasht, Iran"},{"title3":"Evaluation of relationship between the serum levels of inflammatory mediators and ocular injuries induced by sulfur mustard: Sardasht-Iran Cohort Study"},{"title3":"Association of serum immunoglobulins levels and eye injuries in sulfur mustard exposed: Sardasht-Iran Cohort Study"},{"title3":"Are serum levels of immunoglobulin classes and IgG subclasses involved in delayed pulmonary complications induced by sulfur mustard? Sardasht-Iran Cohort Study"},{"title3":"Alterations in the serum levels of chemokines 20years after sulfur mustard exposure: Sardasht-Iran Cohort Study"},{"title3":"The immunostatus of natural killer cells in people exposed to sulfur mustard"},{"title3":"Current status of research on osteoporosis in COPD: a systematic review"},{"title3":"Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis"},{"title3":"Evaluation of serum interleukin-1 beta as an inflammatory marker in COPD patients"},{"title3":"Immunobiological consequences of sulfur mustard contamination"},{"title3":"Shared principles in NF-kappaB signaling"},{"title3":"Late respiratory complications of mustard gas poisoning in Iranian veterans"},{"title3":"Inflammatory status of Non-Smoker Sulphur Mustard exposed Patient with Cancer candidate for Coronary artery bypass grafting Surgery"},{"title3":"Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease"},{"title3":"Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease"},{"title3":"Effect of topically applied sulphur mustard on antioxidant enzymes in blood cells and body tissues of rats"},{"title3":"Alterations in immunoglobulin &amp; complement levels in chronic obstructive pulmonary disease"},{"title3":"Inflammatory mediators in chronic obstructive pulmonary disease"},{"title3":"Epigenetic: A missing paradigm in cellular and molecular pathways of sulfur mustard lung: a prospective and comparative study"},{"title3":"The role of nuclear factor-kappaB in inflammatory lung disease"},{"title3":"Declining bone mass in men with chronic pulmonary disease: contribution of gluco-corticoid treatment, body mass index, and gonadal function"},{"title3":"The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts"},{"title3":"Neither IL-1 beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD"},{"title3":"Osteoporosis in chronic obstructive pulmonary disease patients"},{"title3":"Biomarkers of systemic inflammation in stable and exacerbation phases of COPD"},{"title3":"The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease"},{"title3":"Coronary angiography findings in lung injured patients with sulfur mustard compared to a control group"},{"title3":"Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent"},{"title3":"Serum profiles of matrix metalloproteinases and their tissue inhibitors in long-term pulmonary complication induced by sulfur mustard: Sardasht-Iran Cohort Study (SICS)"},{"title3":"Cigarette smoke stimulates MMP-1 production by human lung fibroblasts through the ERK1/2 pathway"},{"title3":"Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study"},{"title3":"Superoxide dismutase and catalase activity in psoriatic patients treated topically with ointment containing 2-chloroethyl-3-chloropropyl sulfide"},{"title3":"Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis"},{"title3":"The Blood and Bone Marrow in Yelloe Cross Gas (Mustard Gas) Poisoning: Changes produced in the Bone Marrow of Fatal Cases"},{"title3":"Statins, systemic inflammation and risk of death in COPD: the Rotterdam study"},{"title3":"Interleukin-8 induces the endothelial cell migration through the Rac1/RhoA-p38MAPK pathway"},{"title3":"ROS in the local and systemic pathogenesis of COPD"},{"title3":"Inflammatory cytokines and lung toxicity"},{"title3":"Reduced nuclear factor-kappaB repressing factor: a link toward systemic inflammation in COPD"},{"title3":"Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing"},{"title3":"Low-dose sulfur mustard primes oxidative function and induces apoptosis in human polymorphonuclear leukocytes"},{"title3":"The role of selectins in inflammation and disease"},{"title3":"In the clinic. Chronic obstructive pulmonary disease"},{"title3":"Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease"},{"title3":"Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans"},{"title3":"Circulating fibronectin to Creactive protein ratio and mortality: a biomarker in COPD?"},{"title3":"Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study"},{"title3":"The Effects of pulmonary rehabilitation techniques on the clinical status of patients with moderate severity chronic obstructive pulmonary diseases (COPD) at University Hospitals of Isfahan in 2006-7"},{"title3":"Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology"},{"title3":"Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease"},{"title3":"Long-term skin findings of sulfur mustard exposure on the civilians of Sardasht, Iran"},{"title3":"FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure"},{"title3":"Sulfur mustard intoxication, oxidative stress, and antioxidants"},{"title3":"Systemic manifestations of COPD"},{"title3":"Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease"},{"title3":"Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy"},{"title3":"NFkappaB gene expression survey in peripheral blood cell of sardasht warfare agent victims 20 years after exposure to sulfur mustard"},{"title3":"Profiling serum biomarkers in patients with COPD: associations with clinical parameters"},{"title3":"C-reactive protein in patients with COPD, control smokers and non-smokers"},{"title3":"Long-term pulmonary complications in sulfur mustard victims of Sardasht, Iran"},{"title3":"Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: SardashtIran Cohort Study"},{"title3":"Chemokines, MMP-9 and PMN elastase in spontaneous sputum of sulfur mustard exposed civilians: Sardasht-Iran Cohort Study"},{"title3":"The role of sample collection timing on interleukin-6 levels in early-onset neonatal sepsis"},{"title3":"Respiratory complications due to sulfur mustard exposure"},{"title3":"Evaluation of serum levels of interleukin-6 and C-reactive protein in mustard lung patients and its relationship with pulmonary complications"},{"title3":"Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments"},{"title3":"Exercise intolerance and chronotropic impairment-The long-term cardiovascular sequelae of mustard gas exposure: A paired-comparative study"},{"title3":"Serum cytokine profiles of Khorasan veterans 23 years after sulfur mustard exposure"},{"title3":"A case control study of cardiovascular health in chemical war disabled Iranian victims"},{"title3":"Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study"},{"title3":"Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin"},{"title3":"Total serum IgE level in COPD patients"},{"title3":"Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD"},{"title3":"Comparative proteome analysis of peripheral neutrophils from sulfur mustard-exposed and COPD patients"},{"title3":"Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysis"},{"title3":"Need to study of systemic markers changes in acute phase of respiratory complication due to sulfur mustard"},{"title3":"Inflammatory statuses of non-smoker mustard lung patient candidate for coronary artery bypass grafting surgery"},{"title3":"The role of serum level of interleukin-6 in severity of pulmonary complications of sulfur mustard injuries"},{"title3":"Extra cellular Superoxide Dismutase activity in lung injuries due to Sulfur Mustard"},{"title3":"Serum matrix metalloproteinase levels in patients exposed to sulfur mustard"},{"title3":"C-reactive protein, inflammation and coronary heart disease"},{"title3":"Pulmonary cachexia"},{"title3":"P- selectin glycoprotein ligand-1 (PSGL-1) is up-regulated on leucocytes from patients with chronic obstructive pulmonary disease"},{"title3":"Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study"},{"title3":"Dietary factors and their relation to respiratory symptoms the second national health and nutrition examination survey"},{"title3":"Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I)"},{"title3":"Control of lymphocyte development by nuclear factor-kappaB"},{"title3":"Vitamins E and C, beta-carotene, and other carotenoids as antioxidants"},{"title3":"Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease"},{"title3":"Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I"},{"title3":"Ventilatory function and winter fresh fruit consumption in a random sample of British adults"},{"title3":"Role of tumor necrosis factor-alpha in disease states and inflammation"},{"title3":"Fruit and fish consumption: a possible explanation for population differences in COPD mortality (The Seven Countries Study)"},{"title3":"The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard"},{"title3":"The role of cytokines in human lung fibrosis"},{"title3":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry"},{"title3":"Respiratory symptoms, COPD severity, and health related quality of life in a general population sample"},{"title3":"Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity"},{"title3":"Systemic effects in COPD"},{"title3":"The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy"},{"title3":"C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases"},{"title3":"Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20 years after sulfur mustard exposure: Sardasht-Iran cohort study"},{"title3":"Alterations in the serum levels of soluble L, P and E-selectin 20years after sulfur mustard exposure: Sardasht-Iran Cohort Study"},{"title3":"Fibrinogen and inflammatory cytokines in spontaneous sputum of sulfur-mustard-exposed civilians:Sardasht-Iran Cohort Study"},{"title3":"The effect of breathing exercises on the fatigue levels of patients with chronic obstructive pulmonary disease"},{"title3":"Defects of cell-mediatedimmunity in mustard gas injury after years"}]},{"title2":"Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysis","References":[{"title3":"Cardiac surgery anesthesia and systemic inflammatory response"},{"title3":"Long-term skin findings of sulfur mustard exposure on the civilians of Sardasht, Iran"},{"title3":"Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy"},{"title3":"Inflammatory statuses of non-smoker mustard lung patient candidate for coronary artery bypass grafting surgery"},{"title3":"Inflammatory status of non-smoker sulphur mustard exposed patient with cancer candidate for coronary artery bypass grafting surgery"},{"title3":"Respiratory complications due to sulfur mustard exposure"},{"title3":"Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans"},{"title3":"Long term consequences from exposure to sulfur mustard: a review"},{"title3":"Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease"},{"title3":"Inhalation of alkylating mustard causes long-term T cell-dependent inflammation in airways and growth of connective tissue"},{"title3":"Systemic effects of chronic obstructive pulmonary disease"},{"title3":"Pulmonary function is a long-term predictor of mortality in the general population 29-year follow-up of the Buffalo Health Study"},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning"},{"title3":"Tracheobronchomalacia and air trapping after mustard gas exposure"},{"title3":"Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases"},{"title3":"Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease"},{"title3":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis"},{"title3":"IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study"},{"title3":"Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis"},{"title3":"lnterleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease"},{"title3":"Association of cytokines genes (ILL, IL1RN, TNF, LTA, IL6, IL8, IL0) polymorphic markers with chronic obstructive pulmonary disease"},{"title3":"Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin"},{"title3":"Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients"},{"title3":"Inflammatory changes, recovery and recurrence at COPD exacerbation"},{"title3":"High serum levels of tumour necrosis factor alpha and interleukin-8 in severe asthma: markers of systemic inflammation?"},{"title3":"Cytokines in chronic obstructive pulmonary disease"},{"title3":"Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma"},{"title3":"Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma"},{"title3":"Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8"},{"title3":"Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans"},{"title3":"Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation"},{"title3":"Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland"},{"title3":"Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease"},{"title3":"Detection and significance of interleukin-8, 6, tumor necrosis factor-alpha in sputa from patients with chronic obstructive pulmonary disease"},{"title3":"Airway inflammation in COPD assessed by sputum levels of interleukin-8"},{"title3":"An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients"},{"title3":"Airway and systemic inflammation and decline in lung function in patients with COPD"},{"title3":"Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum"}]},{"title2":"Need to study of systemic markers changes in acute phase of respiratory complication due to sulfur mustard","References":[]},{"title2":"Evaluation of serum levels of interleukin-6 and C-reactive protein in mustard lung patients and its relationship with pulmonary complications","References":[]},{"title2":"NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations","References":[]},{"title2":"Clinical applications of metabolomics in oncology: a review","References":[{"title3":"Metabolomics:the link between genotypes and phenotypes"},{"title3":"Metabolic profiles of cancer cells"},{"title3":"Snapshots of systems: metabolic control analysis and biotechnology in the post-genomic era"},{"title3":"Metabolomics: The greatest omics of them all?"},{"title3":"Measuring the metabolome: current analytical technologies"},{"title3":"Metabolic profiling allows comprehensive phenotyping of genetically or environmentally modified plant systems"},{"title3":"[1,2-13C2]-d-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats"},{"title3":"Why and when channeling can decrease pool size at constant net flux in a simple dynamic channel"},{"title3":"Channelling can decrease pool size"},{"title3":"Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma"},{"title3":"NMR-based metabolomics: translational application and treatment of cancer"},{"title3":"Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism"},{"title3":"Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics"},{"title3":"Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors"},{"title3":"Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics"},{"title3":"Metabolic profiles of human brain tumors using quantitative in vivo1H magnetic resonance spectroscopy"},{"title3":"MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status"},{"title3":"Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection"},{"title3":"Pretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks"},{"title3":"Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways"},{"title3":"Mass spectrometry-based metabolomics"},{"title3":"Metabolomics technology and bioinformatics"},{"title3":"NMR-based metabolomics"},{"title3":"Metabolomic analysis using optimized NMR and statistical methods"},{"title3":"Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics"},{"title3":"From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics"},{"title3":"Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry"},{"title3":"Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine"},{"title3":"Metabolomics: quantification of intracellular metabolite dynamics"},{"title3":"Data mining in genomics"},{"title3":"Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra"},{"title3":"HMDB: human metabolome database"},{"title3":"The tumor metabolome"},{"title3":"Choline phospholipid metabolism: a target in cancer cells?"},{"title3":"Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD"},{"title3":"Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study"},{"title3":"Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy:initial results"},{"title3":"In vivo quantification of choline compounds in the breast with 1H MR spectroscopy"},{"title3":"Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T"},{"title3":"Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy"},{"title3":"Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters"},{"title3":"Molecular causes of the aberrant choline phospholipid metabolism in breast cancer"},{"title3":"Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy"},{"title3":"Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T"},{"title3":"Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy"},{"title3":"Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study"},{"title3":"Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging"},{"title3":"Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies"},{"title3":"Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy"},{"title3":"Pre-operative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens"},{"title3":"Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer"},{"title3":"Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy"},{"title3":"Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging"},{"title3":"Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse"},{"title3":"Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report"},{"title3":"Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development"},{"title3":"Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells"},{"title3":"Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications"},{"title3":"FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphori-bosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis"},{"title3":"Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy"},{"title3":"Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas"},{"title3":"Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy"},{"title3":"Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models"},{"title3":"CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs"},{"title3":"The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells"},{"title3":"Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase"},{"title3":"Apoptosis and therapy"},{"title3":"Hypoxic cervical cancers with low apoptotic index are highly aggressive"},{"title3":"Heat shock protein 90: the cancer chaperone"},{"title3":"The role of analytical sciences in medical systems biology"},{"title3":"Clinical potential of proteomics in the diagnosis of ovarian cancer"},{"title3":"Secreted and cell surface genes expressed in benign and malignant colorectal tumors"},{"title3":"Use of proteomic patterns in serum to identify ovarian cancer"},{"title3":"Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate"},{"title3":"Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity"},{"title3":"Sunitinib (SU) response in imatinib-resistant (IM-R) GIST correlates with KIT and PDGFRA mutation status"},{"title3":"The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors"},{"title3":"CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor"},{"title3":"Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy"},{"title3":"Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review"},{"title3":"Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer"},{"title3":"Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET"},{"title3":"The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival"},{"title3":"Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants"},{"title3":"Metabonomic investigations into hydrazine toxicity in the rat"},{"title3":"Comparative studies on the nephrotoxicity of 2-bromoethanamine hydrobromide in the Fischer 344 rat and the multimammate desert mouse (Mastomys natalensis)"},{"title3":"Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks"},{"title3":"Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics"},{"title3":"Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition"},{"title3":"An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy"},{"title3":"Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins"}]},{"title2":"Metabolomics and cardiovascular biomarker discovery","References":[]},{"title2":"Metabolomics in diabetes, a review","References":[{"title3":"2006"},{"title3":"International Diabetes Federation"},{"title3":"2022"},{"title3":"The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis"},{"title3":"COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission"},{"title3":"Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis"},{"title3":"The Worrying Trend of Diabetes Mellitus in Saudi Arabia: An Urgent Call to Action"},{"title3":"COVID-19 among people with diabetes millitus in Saudi Arabia: current situation and new perspectives"},{"title3":"Standards of Medical Care in Diabetes-2019 Abridged for Primary Care Providers"},{"title3":"Should metformin remain the first-line therapy for treatment of type 2 diabetes?"},{"title3":"Cellular and molecular mechanisms of metformin: an overview"},{"title3":"Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017"},{"title3":"Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review"},{"title3":"Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin"},{"title3":"Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome"},{"title3":"Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study"},{"title3":"The Long-term Effects of Metformin on Patients with Type 2 Diabetic Kidney Disease"},{"title3":"Metformin: the updated protective property in kidney disease"},{"title3":"Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care"},{"title3":"Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin"},{"title3":"1990"},{"title3":"Differing effects of metformin on glycemic control by race-ethnicity"},{"title3":"Pharmacogenomics: precision medicine and drug response"},{"title3":"Genetic polymorphisms in organic cation transporter 1 attenuates hepatic metformin exposure in humans"},{"title3":"Metabolomics of Type 1 and Type 2 Diabetes"},{"title3":"AMP-activated protein kinase: a target for drugs both ancient and modern"},{"title3":"J Pharm Sci"},{"title3":"A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators"},{"title3":"OCT1 Polyspecificity:Friend or Foe?"},{"title3":"et al. Specific OCT1 and ABCG2 Polymorphisms Are Associated with Lamotrigine Concentrations in Chinese Patients with Epilepsy"},{"title3":"Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency"},{"title3":"Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models"},{"title3":"Four cationselective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers"},{"title3":"Targeted Disruption of Organic Cation Transporter 3 Attenuates the Pharmacologic Response to Metformin"},{"title3":"The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition"},{"title3":"Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin"},{"title3":"Metformin pharmacogenomics: current status and future directions"},{"title3":"Comparative Bioavailability and Pharmacokinetics Between the Solid Form of Metformin vs a Novel Liquid Extemporaneous Formulation in Children"},{"title3":"The mechanisms of action of metformin"},{"title3":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain"},{"title3":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I"},{"title3":"Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation"},{"title3":"Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes"},{"title3":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin"},{"title3":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase"},{"title3":"Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes"},{"title3":"Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity"},{"title3":"New insights into the anti-diabetic actions of metformin: from the liver to the gut"},{"title3":"Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids"},{"title3":"Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites"},{"title3":"Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences, Pharmacogenet"},{"title3":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action"},{"title3":"The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c, Pharmacogenet"},{"title3":"Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study"},{"title3":"Genetic variants of OCT1 influence glycemic response to metformin in Han Chinese patients with type-2 diabetes mellitus in Shanghai"},{"title3":"The impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 polymorphisms on metformin therapeutic efficacy in Chinese type 2 diabetes patients"},{"title3":"Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin"},{"title3":"Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study"},{"title3":"Molecular mechanism of action of metformin: old or new insights?"},{"title3":"Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis"},{"title3":"Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin"},{"title3":"Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program"},{"title3":"Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes"},{"title3":"Variants of transcription factor 7- like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucoseregulation and impaired insulin secretion"},{"title3":"Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults"},{"title3":"Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. study"},{"title3":"Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism"},{"title3":"TCF7L2 rs7903146 polymorphism association with diabetes and obesity in an elderly cohort from Brazil"},{"title3":"The Role of TCF7L2 in Type 2 Diabetes"},{"title3":"Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort"},{"title3":"Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus"},{"title3":"rs622342A&gt;C in SLC22A1 is associated with metformin pharmacokinetics and glycemic response"},{"title3":"Effect of plasma membrane monoamine transporter genetic variants on pharmacokinetics of metformin in humans"},{"title3":"Effects of SLC22A2 (rs201919874) and SLC47A2 (rs138244461) genetic variants on Metformin Pharmacokinetics in Pakistani T2DM patients"},{"title3":"Using EHR-linked biobank data to study metformin pharmacogenomics"},{"title3":"OCT3 promoter haplotype is associated with metformin pharmacokinetics in Koreans"},{"title3":"Results of studying the association between the rs11212617 polymorphism in the ATM gene and response to metformin therapy in patients with type 2 diabetes mellitus"},{"title3":"Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients"},{"title3":"Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis"},{"title3":"Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting"},{"title3":"Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition"},{"title3":"The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism"},{"title3":"Amino Acid-Related Metabolic Signature in Obese Children and Adolescents"},{"title3":"Biomarkers for predicting type 2 diabetes development:Can metabolomics improve on existing biomarkers?"},{"title3":"Specific metabolic profiles and their relationship to insulin resistance in recent-onset type-1and type-2 diabetes"},{"title3":"Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated with Metformin"},{"title3":"Metformin effect on nontargeted metabolite profiles in patients with type 2 diabetes and in multiple murine tissues"},{"title3":"2015. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes"}]},{"title2":"Metabolic profiling detects biomarkers of protein degradation in COPD patients","References":[]},{"title2":"Phenotyping COPD by 1H NMR metabolomics of exhaled breath condensate","References":[]},{"title2":"Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotoxin-lysoPA axis in COPD","References":[{"title3":"Global burden of COPD: risk factors, prevalence, and future trends"},{"title3":"Metabolomic profiling of asthma and chronic obstructive pulmonary disease: a pilot study differentiating diseases"},{"title3":"Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies"},{"title3":"Gender and chronic obstructive pulmonary disease: why it matters"},{"title3":"Gender differences in COPD: are women more susceptible to smoking effects than men?"},{"title3":"Sex differences in emphysema and airway disease in smokers"},{"title3":"An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease"},{"title3":"Progression from asthma to chronic obstructive pulmonary disease. Is air pollution a risk factor?"},{"title3":"Pulmonary health effects of air pollution"},{"title3":"Free radicals and antioxidants in normal physiological functions and human disease"},{"title3":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary"},{"title3":"Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease"},{"title3":"Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction"},{"title3":"Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers"},{"title3":"Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD"},{"title3":"Metabolomics analysis identifies different metabotypes of asthma severity"},{"title3":"HMDB 3.0 - the Human Metabolome Database in 2013"},{"title3":"LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFalpha treatment"},{"title3":"Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation"},{"title3":"The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans"},{"title3":"Influence of missing values substitutes on multivariate analysis of metabolomics data"},{"title3":"Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine"},{"title3":"Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models"},{"title3":"Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA"},{"title3":"MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD"},{"title3":"Unravelling the complexity of COPD by microRNAs: it's a small world after all"},{"title3":"MicroRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease"},{"title3":"Inhibition of the phospholipase A2 activity of peroxiredoxin 6 prevents lung damage with exposure to hyperoxia"},{"title3":"Incapacity, handicap, and oxidative stress markers of male smokers with and without COPD"},{"title3":"Metabolomics screening identifies reduced l-carnitine to be associated with progressive emphysema"},{"title3":"Extracellular adenosine triphosphate and chronic obstructive pulmonary disease"},{"title3":"Sex differences in airway remodeling in a mouse model of chronic obstructive pulmonary disease"},{"title3":"Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD"},{"title3":"l-Arginine pathway in COPD patients with acute exacerbation: a new potential biomarker"},{"title3":"Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)"},{"title3":"Asymmetric dimethylarginine is increased in asthma"},{"title3":"Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease"},{"title3":"Regulation and biological activities of the autotaxin-LPA axis"},{"title3":"Favorable human safety, pharmacokinetics and pharmacodynamics of the autotaxin inhibitor GLPG1690, a potential new treatment in COPD"},{"title3":"Airway epithelial miRNA expression is altered in asthma"},{"title3":"The role of miR-29 in pulmonary fibrosis"},{"title3":"Diverse roles of miR-29 in cancer (review)"},{"title3":"c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT"},{"title3":"Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2/autotaxin exacerbates hyperoxic lung injury"},{"title3":"Autotaxin-LPA receptor axis in the pathogenesis of lung diseases"},{"title3":"Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation"},{"title3":"Polyunsaturated lysophosphatidic acid as a potential asthma biomarker"},{"title3":"Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis - a prospective cohort study"},{"title3":"The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation"},{"title3":"Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation"},{"title3":"12-hydroxyeicosatetraenoic acid is associated with variability in aspirin-induced platelet inhibition"},{"title3":"Steroid binding to autotaxin links bile salts and lysophosphatidic acid signalling"}]},{"title2":"Machine learning: applications of artificial intelligence to imaging and diagnosis","References":[]},{"title2":"The practical implementation of artificial intelligence technologies in medicine","References":[{"title3":"Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs"},{"title3":"Identifying medical diagnoses and treatable diseases by image-based deep learning"},{"title3":"Dermatologist-level classification of skin cancer with deep neural networks"},{"title3":"Computer-aided diagnosis with deep learning architecture: applications to breast lesions in US images and pulmonary nodules in CT scans"},{"title3":"The inevitable application of big data to health care"},{"title3":"Artificial intelligence in healthcare: past, present and future"},{"title3":"Artificial intelligence in cardiology"},{"title3":"Canadian association of radiologists white paper on artificial intelligence in radiology"},{"title3":"Artificial intelligence in healthcare: Babylon Health &amp; IBM Watson take the lead"},{"title3":"Clinically applicable deep learning for diagnosis and referral in retinal disease"},{"title3":"Cardiac imaging: working towards fully-automated machine analysis &amp; interpretation"},{"title3":"Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks"},{"title3":"Integrated precision medicine: the role of electronic health records in delivering personalized treatment"},{"title3":"Executive Office of the President &amp; National Science and Technology Council Committee on Technology"},{"title3":"When machines think: radiology's next frontier"},{"title3":"Global research on artificial intelligence from 1990-2014: spatially-explicit bibliometric analysis"},{"title3":"From Virtual Nurses To Drug Discovery: 106 Artificial Intelligence Startups InHealthcare"},{"title3":"Implementing machine learning in health care:addressing ethical challenges"},{"title3":"National Science and Technology Council Committee on Technology Council &amp; Networking and Information Technology Research and Development Subcomittee"},{"title3":"The Cardiac Atlas Project:an imaging database for computational modeling and statistical atlases of the heart"},{"title3":"Cloud-based evaluation of anatomical structure segmentation and landmark detection algorithms: VISCERAL anatomy benchmarks"},{"title3":"Artificial Intelligence for the American People"},{"title3":"Artificial intelligence in surgery: promises and perils"},{"title3":"Human-like machines: transparency and comprehensibility"},{"title3":"Opening the black box: low-dimensional dynamics in high-dimensional recurrent neural networks"},{"title3":"Challenges and opportunities of big data in health care: a systematic review"},{"title3":"How long it takes the US FDA to approve 510(k) submissions"},{"title3":"University of Iowa Health Care First to Adopt IDx-DR in a Diabetes Care Setting"},{"title3":"European Union regulations on algorithmic decision-making and a 'right to explanation"},{"title3":"4 ways the ACR's Data Science Institute is looking to implement AI in clinical practice"}]},{"title2":"Dermatologist-level classification of skin cancer with deep neural networks","References":[]},{"title2":"End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography","References":[]},{"title2":"Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study","References":[]},{"title2":"Deep learning algorithms for detection of lymph node metastases from breast cancer: helping artificial intelligence be seen","References":[]},{"title2":"Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study","References":[]},{"title2":"Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis","References":[{"title3":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary"},{"title3":"Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function"},{"title3":"Genome-wide association study identifies five loci associated with lung function"},{"title3":"Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function"},{"title3":"Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function"},{"title3":"Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation"},{"title3":"Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank"},{"title3":"Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis"},{"title3":"Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia"},{"title3":"A common 16p11.2 inversion underlies the joint susceptibility to asthma and obesity"},{"title3":"The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency"},{"title3":"Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes"},{"title3":"Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis"},{"title3":"Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report"},{"title3":"Global burden of COPD: risk factors, prevalence, and future trends"},{"title3":"A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci"},{"title3":"Variants in FAM13A are associated with chronic obstructive pulmonary disease"},{"title3":"A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13"},{"title3":"Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease"},{"title3":"A genome-wide association study of pulmonary function measures in the Framingham Heart Study"},{"title3":"Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction"},{"title3":"Lung eQTLs to help reveal the molecular underpinnings of asthma"},{"title3":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics"},{"title3":"Desmoplakin is essential in epidermal sheet formation"},{"title3":"The novel PAR-1-binding protein MTCL1 has crucial roles in organizing microtubules in polarizing epithelial cells"},{"title3":"MTCL1 crosslinks and stabilizes non-centrosomal microtubules on the Golgi membrane"},{"title3":"Proteomics. Tissue-based map of the human proteome"},{"title3":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants"},{"title3":"HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease"},{"title3":"The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy"},{"title3":"The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy"},{"title3":"Suppression of NLRX1 in chronic obstructive pulmonary disease"},{"title3":"Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice"},{"title3":"Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD"},{"title3":"Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease"},{"title3":"Desmoplakin Variants Are Associated with Idiopathic Pulmonary Fibrosis"},{"title3":"Detection and interpretation of shared genetic influences on 42 human traits"},{"title3":"Lung volumes and emphysema in smokers with interstitial lung abnormalities"},{"title3":"The pathogenesis of COPD and IPF: distinct horns of the same devil?"},{"title3":"Telomerase mutations in smokers with severe emphysema"},{"title3":"The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom"},{"title3":"The NHGRI GWAS Catalog, a curated resource of SNP-trait associations"},{"title3":"A large-scale, consortium-based genomewide association study of asthma"},{"title3":"Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior"},{"title3":"Genome-wide meta-analyses identify multiple loci associated with smoking behavior"},{"title3":"Partitioning heritability by functional annotation using genome-wide association summary statistics"},{"title3":"An atlas of genetic correlations across human diseases and traits"},{"title3":"Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema"},{"title3":"Leveraging Multi-ethnic Evidence for Mapping Complex Traits in Minority Populations: An Empirical Bayes Approach"},{"title3":"Large-scale association analysis identifies new risk loci for coronary artery disease"},{"title3":"Defining the role of common variation in the genomic and biological architecture of adult human height"},{"title3":"Genetic studies of body mass index yield new insights for obesity biology"},{"title3":"Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture"},{"title3":"The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility"},{"title3":"Quality control and conduct of genome-wide association meta-analyses"},{"title3":"METAL MetaAnalysis Helper"},{"title3":"METAL: fast and efficient meta-analysis of genomewide association scans"},{"title3":"GCTA: a tool for genome-wide complex trait analysis"},{"title3":"Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits"},{"title3":"Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls"},{"title3":"Molecular signature of smoking in human lung tissues"},{"title3":"Genetic regulation of gene expression in the lung identifies CST3 and CD22 as potential causal genes for airflow obstruction"},{"title3":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome"},{"title3":"PLINK: a tool set for whole-genome association and population-based linkage analyses"},{"title3":"Second-generation PLINK: rising to the challenge of larger and richer datasets"},{"title3":"The clinical and genetic features of COPD-asthma overlap syndrome"},{"title3":"Bayes factors for genome-wide association studies: comparison with P-values"},{"title3":"Transethnic meta-analysis of genomewide association studies"},{"title3":"Leveraging Functional-Annotation Data in Trans-ethnic Fine-Mapping Studies"},{"title3":"Integrative Tissue-Specific Functional Annotations in the Human Genome Provide Novel Insights on Many Complex Traits and Improve Signal Prioritization in Genome Wide Association Studies"},{"title3":"Disentangling the Effects of Colocalizing Genomic Annotations to Functionally Prioritize Non-coding Variants within Complex-Trait Loci"},{"title3":"SNPsea: an algorithm to identify cell types, tissues and pathways affected by risk loci"},{"title3":"Selecting causal genes from genome-wide association studies via functionally coherent subnetworks"},{"title3":"The International HapMap Project"},{"title3":"A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes"},{"title3":"i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study"},{"title3":"KEGG: kyoto encyclopedia of genes and genomes"},{"title3":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium"},{"title3":"Gene Ontology Consortium: going forward"}]},{"title2":"icoshift: A versatile tool for the rapid alignment of 1D NMR spectra","References":[]},{"title2":"HMDB 4.0: the human metabolome database for 2018","References":[{"title3":"Metabolomics: applications to food science and nutrition research"},{"title3":"Current progress in computational metabolomics"},{"title3":"GenBank"},{"title3":"UniProt: the universal protein knowledgebase"},{"title3":"KEGG: new perspectives on genomes, pathways, diseases and drugs"},{"title3":"The Reactome pathway Knowledgebase"},{"title3":"The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases"},{"title3":"METLIN: a metabolite mass spectral database"},{"title3":"MetaboLights: an open-access database repository for metabolomics data"},{"title3":"Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools"},{"title3":"LMSD: LIPID MAPS structure database"},{"title3":"HMDB: the Human Metabolome Database"},{"title3":"Proteomics and the human metabolome project"},{"title3":"HMDB: a knowledgebase for the human metabolome"},{"title3":"HMDB 3.0:the Human Metabolome Database in 2013"},{"title3":"Illuminating the dark matter in metabolomics"},{"title3":"Current and future perspectives on the structural identification of small molecules in biological systems"},{"title3":"The University of Minnesota Biocatalysis/Biodegradation Database: improving public access"},{"title3":"CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra"},{"title3":"MINEs: open access databases of computationally predicted enzyme promiscuity products for untargeted metabolomics"},{"title3":"SPLASH, a hashed identifier for mass spectra"},{"title3":"mzML: a single, unifying data format for mass spectrometer output"},{"title3":"ClassyFire: automated chemical classification with a comprehensive, computable taxonomy"},{"title3":"Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking"},{"title3":"Construction of an ultrahigh pressure liquid chromatography-tandem mass spectral library of plant natural products and comparative spectral analyses"},{"title3":"MassBank: a public repository for sharing mass spectral data for life sciences"},{"title3":"BioMagResBank"},{"title3":"SMPDB: the Small Molecule Pathway Database"},{"title3":"Pathways with PathWhiz"},{"title3":"SMPDB 2.0: big improvements to the Small Molecule Pathway Database"},{"title3":"ChEBI in 2016: Improved services and an expanding collection of metabolites"},{"title3":"PubChem Substance and Compound databases"},{"title3":"The human urine metabolome"},{"title3":"The Human Saliva Metabolome"},{"title3":"Computational Prediction of Electron Ionization Mass Spectra to Assist in GC/MS Compound Identification"},{"title3":"Expansion of the Gene Ontology knowledgebase and resources"},{"title3":"PolySearch2: a significantly improved text-mining system for discovering associations between human diseases, genes, drugs, metabolites, toxins and more"},{"title3":"Metabolomic signatures for drug response phenotypes: pharmacometabolomics enables precision medicine"},{"title3":"DrugBank 4.0: shedding new light on drug metabolism"},{"title3":"Genetics of human metabolism: an update"},{"title3":"Exposome-Explorer: a manually-curated database on biomarkers of exposure to dietary and environmental factors"}]},{"title2":"MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis","References":[{"title3":"MetaboAnalyst: a web server for metabolomic data analysis and interpretation"},{"title3":"MetaboAnalyst 2.0:a comprehensive server for metabolomic data analysis"},{"title3":"MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data"},{"title3":"MetPA: a web-based metabolomics tool for pathway analysis and visualization"},{"title3":"MetATT: a web-based metabolomics tool for analyzing time-series and two-factor datasets"},{"title3":"MetaboAnalyst 3.0:making metabolomics more meaningful"},{"title3":"Translational biomarker discovery in clinical metabolomics: an introductory tutorial"},{"title3":"Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences"},{"title3":"Metabotyping reveals distinct metabolic alterations in ketotic cows and identifies early predictive serum biomarkers for the risk of disease"},{"title3":"Enteric helminths promote Salmonella coinfection by altering the intestinal metabolome"},{"title3":"Metabolomic analysis for first-trimester Down syndrome prediction"},{"title3":"Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth"},{"title3":"Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity"},{"title3":"Distinctive pattern of serum elements during the progression of Alzheimer's disease"},{"title3":"Predicting network activity from high throughput metabolomics"},{"title3":"Accurate, fully-automated NMR spectral profiling for metabolomics"},{"title3":"Systems biology guided by XCMS Online metabolomics"},{"title3":"Impact of outdated gene annotations on pathway enrichment analysis"},{"title3":"Evaluation and comparison of bioinformatic tools for the enrichment analysis of metabolomics data"},{"title3":"KEGG: new perspectives on genomes, pathways, diseases and drugs"},{"title3":"HMDB 4.0: the human metabolome database for 2018"},{"title3":"The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013"},{"title3":"METLIN: a metabolite mass spectral database"},{"title3":"PubChem substance and compound databases"},{"title3":"SMPDB 2.0: big improvements to the small molecule pathway database"},{"title3":"MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data"},{"title3":"MetAlign 3.0: performance enhancement by efficient use of advances in computer hardware"},{"title3":"Metabolomic database annotations via query of elemental compositions: mass accuracy is insufficient even at less than 1 ppm"},{"title3":"Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry"},{"title3":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles"},{"title3":"Metabolomics: beyond biomarkers and towards mechanisms"},{"title3":"Mining the plasma proteome for cancer biomarkers"},{"title3":"Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities"},{"title3":"Design and analysis of metabolomics studies in epidemiologic research: a primer on-omic technologies"},{"title3":"Comprehensive literature review and statistical considerations for microarray meta-analysis"},{"title3":"Innovation: Metabolomics: the apogee of the omics trilogy"},{"title3":"INMEX-a web-based tool for integrative meta-analysis of expression data"},{"title3":"Microarray meta-analysis and cross-platform normalization: integrative genomics for robust biomarker discovery"},{"title3":"Analysis of metabolomic data: tools, current strategies and future challenges for omics data integration"},{"title3":"Methods of integrating data to uncover genotype-phenotype interactions"},{"title3":"Computational approaches for integrative analysis of the metabolome and microbiome"},{"title3":"NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data"},{"title3":"Global prioritization of disease candidate metabolites based on a multi-omics composite network"},{"title3":"Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses"},{"title3":"Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems"},{"title3":"Workflow4Metabolomics: a collaborative research infrastructure for computational metabolomics"},{"title3":"Galaxy-M: a Galaxy workflow for processing and analyzing direct infusion and liquid chromatography mass spectrometry-based metabolomics data"},{"title3":"Metabox: A toolbox for metabolomic data analysis, interpretation and integrative exploration"}]},{"title2":"Metabolism and disease","References":[]},{"title2":"Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort","References":[]},{"title2":"The role of leucine in weight loss diets and glucose homeostasis","References":[]},{"title2":"Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease","References":[]},{"title2":"Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD","References":[]},{"title2":"Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease","References":[]},{"title2":"Possible mechanisms underlying the development of cachexia in COPD","References":[]},{"title2":"Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective","References":[{"title3":"Projections of global mortality and burden of disease from 2002 to 2030"},{"title3":"The burden of disease in older people and implications for health policy and practice"},{"title3":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary"},{"title3":"Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease"},{"title3":"Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality"},{"title3":"Bone attenuation on routine chest CT correlates with bone mineral density on DXA in patients with COPD"},{"title3":"Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation"},{"title3":"Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study"},{"title3":"Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease"},{"title3":"Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD"},{"title3":"Body composition and mortality in chronic obstructive pulmonary disease"},{"title3":"Peripheral muscle weakness in patients with chronic obstructive pulmonary disease"},{"title3":"Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease"},{"title3":"Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease"},{"title3":"Comparative assessment of the quadriceps and the diaphragm in patients with COPD"},{"title3":"Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease"},{"title3":"Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure"},{"title3":"Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease"},{"title3":"Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD"},{"title3":"The mechanisms of cachexia underlying muscle dysfunction in COPD"},{"title3":"A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting"},{"title3":"Differential sensitivity of oxidative and glycolytic muscles to hypoxia-induced muscle atrophy"},{"title3":"Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD"},{"title3":"Nutritional assessment and therapy in COPD: a European Respiratory Society statement"},{"title3":"Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation"},{"title3":"Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years"},{"title3":"When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences"},{"title3":"Respiratory function and the obesity paradox"},{"title3":"The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease"},{"title3":"Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease"},{"title3":"San Jose Estepar R, Zhou L, Regan EA et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study"},{"title3":"Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers"},{"title3":"Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease"},{"title3":"Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments"},{"title3":"Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease"},{"title3":"Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease"},{"title3":"Muscle wasting in emphysema"},{"title3":"Does oxidative stress modulate limb muscle atrophy in severe COPD patients?"},{"title3":"Oxidative Stress, Redox Signaling Pathways, And Autophagy In Cachectic Muscles Of Male Patients With Advanced Copd And Lung Cancer"},{"title3":"Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD"},{"title3":"Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia"},{"title3":"Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease"},{"title3":"Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting"},{"title3":"Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease"},{"title3":"Autophagy in locomotor muscles of patients with chronic obstructive pulmonary disease"},{"title3":"Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD"},{"title3":"Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD"},{"title3":"Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease"},{"title3":"Autophagic flux and oxidative capacity of skeletal muscles during acute starvation"},{"title3":"Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study"},{"title3":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy"},{"title3":"FoxO3 controls autophagy in skeletal muscle in vivo"},{"title3":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction"},{"title3":"Back to the future with ubiquitin"},{"title3":"Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease"},{"title3":"MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease"},{"title3":"Cellular markers of muscle atrophy in chronic obstructive pulmonary disease"},{"title3":"Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle"},{"title3":"An overview of the molecular mechanism of autophagy"},{"title3":"The role of the Atg1/ULK1 complex in autophagy regulation"},{"title3":"Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle"},{"title3":"Autophagy proteins LC3B, ATG5 and ATG12 participate in quality control after mitochondrial damage and influence lifespan"},{"title3":"Autophagic removal of micronuclei"},{"title3":"Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD"},{"title3":"Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients"},{"title3":"Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation"},{"title3":"Upstream and downstream of mTOR"},{"title3":"Activation of satellite cells in the intercostal muscles of patients with chronic obstructive pulmonary disease"},{"title3":"Maximal lengthening contractions induce different signaling responses in the type I and type II fibers of human skeletal muscle"},{"title3":"An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration"},{"title3":"Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage"},{"title3":"Cellular and molecular responses to increased skeletal muscle loading after irradiation"},{"title3":"Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease"},{"title3":"Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease"},{"title3":"Apoptosis in skeletal muscle and its relevance to atrophy"},{"title3":"Nucleophagy at a glance"},{"title3":"Satellite cells in human skeletal muscle; from birth to old age"},{"title3":"The impact of sarcopenia and exercise training on skeletal muscle satellite cells"},{"title3":"Physical performance and muscular characteristics in different stages of COPD"},{"title3":"Satellite cells senescence in limb muscle of severe patients with COPD"},{"title3":"Inflammatory and satellite cells in the quadriceps of patients with COPD and response to resistance training"},{"title3":"Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways"},{"title3":"Quadriceps myostatin expression in COPD"},{"title3":"Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease"},{"title3":"The skeletal muscle satellite cell response to a single bout of resistance-type exercise is delayed with aging in men"},{"title3":"Scaling skeletal muscle function to mass in patients with moderate-to-severe COPD"},{"title3":"Relationship between peripheral muscle structure and function in patients with chronic obstructive pulmonary disease with different nutritional status"},{"title3":"Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD"},{"title3":"Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis"},{"title3":"Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease"},{"title3":"Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms"},{"title3":"Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives"},{"title3":"Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice"},{"title3":"Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy"},{"title3":"Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases"},{"title3":"Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD"},{"title3":"Intake of branched-chain amino acids influences the levels of MAFbx mRNA and MuRF-1 total protein in resting and exercising human muscle"},{"title3":"Skeletal muscle molecular responses to resistance training and dietary supplementation in COPD"},{"title3":"Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism"},{"title3":"Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis"},{"title3":"The ATM protein kinase and cellular redox signaling: beyond the DNA damage response"},{"title3":"mTOR and cancer: insights into a complex relationship"},{"title3":"Autophagy is required for exercise training-induced skeletal muscle adaptation and improvement of physical performance"},{"title3":"Autophagy is essential to support skeletal muscle plasticity in response to endurance exercise"},{"title3":"Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease"},{"title3":"Effects of different intensities of resistance exercise on regulators of myogenesis"},{"title3":"Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage"},{"title3":"Acute dietary protein intake restriction is associated with changes in myostatin expression after a single bout of resistance exercise in healthy young men"},{"title3":"Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease"},{"title3":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy"},{"title3":"Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by tumor necrosis factor-alpha"},{"title3":"Effects of anabolic steroids on chronic obstructive pulmonary disease: a meta-analysis of randomised controlled trials"},{"title3":"Nutrition as a metabolic modulator in COPD"},{"title3":"A dual-respiration chamber system with automated calibration"},{"title3":"Use of the doubly labeled water method for measurement of energy expenditure, total body water, water intake, and metabolizable energy intake in humans and small animals"},{"title3":"Energy expenditure by doubly labeled water: validation in humans and proposed calculation"},{"title3":"The daily energy expenditure in stable chronic obstructive pulmonary disease"},{"title3":"Total energy expenditure in underweight patients with severe chronic obstructive pulmonary disease living at home"},{"title3":"Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD"},{"title3":"Resting energy expenditure and metabolic changes after lung volume reduction surgery for emphysema"},{"title3":"Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease"},{"title3":"Resting energy expenditure in patients with chronic obstructive pulmonary disease"},{"title3":"Energy expenditure in patients with chronic obstructive pulmonary disease"},{"title3":"Body composition and resting energy expenditure in clinically stable, non-weight-losing patients with severe emphysema"},{"title3":"The thermic effect of food in underweight patients with emphysematous chronic obstructive pulmonary disease"},{"title3":"Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD"},{"title3":"Energy balance in stable malnourished patients with chronic obstructive pulmonary disease"},{"title3":"Consequences of inadequate food energy and negative energy balance in humans"},{"title3":"Staal-van den Brekel AJ, Wouters EF. Energy balance in nonsmall cell lung carcinoma patients before and after surgical resection of their tumors"},{"title3":"Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy"},{"title3":"Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls"},{"title3":"Resting energy expenditure and body composition in patients with newly detected cancer"},{"title3":"Daily physical activity in subjects with newly diagnosed COPD"},{"title3":"Physical activity level and its clinical correlates in chronic obstructive pulmonary disease: a cross-sectional study"},{"title3":"Physical inactivity in patients with COPD, a controlled multi-center pilot-study"},{"title3":"Characteristics of physical activities in daily life in chronic obstructive pulmonary disease"},{"title3":"A longitudinal study evaluating the effect of exacerbations on physical activity in patients with chronic obstructive pulmonary disease"},{"title3":"Physical activity and hospitalization for exacerbation of COPD"},{"title3":"Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study"},{"title3":"Improved exercise performance following lung volume reduction surgery for emphysema"},{"title3":"Daily physical activity after bronchoscopic lung volume reduction: a pilot study"},{"title3":"Physiologic limitations during daily life activities in COPD patients"},{"title3":"Task-related oxygen uptake during domestic activities of daily life in patients with COPD and healthy elderly subjects"},{"title3":"Plasma ammonia response to incremental cycling and walking tests in COPD"},{"title3":"Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise"},{"title3":"Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation"},{"title3":"Low physical activity levels and functional decline in individuals with lung cancer"},{"title3":"Physical performance and psychosocial status in lung cancer patients: results from a pilot study"},{"title3":"Diet-induced thermogenesis in chronic obstructive pulmonary disease"},{"title3":"Role of the thermic effect of food in malnutrition of patients with chronic obstructive pulmonary disease"},{"title3":"Total daily energy expenditure in wasted chronic obstructive pulmonary disease patients"},{"title3":"Transcutaneous oxygen saturation and carbon dioxide tension during meals in patients with chronic obstructive pulmonary disease"},{"title3":"Raised CRP levels mark metabolic and functional impairment in advanced COPD"},{"title3":"Analysis of the energy balance in lung cancer patients"},{"title3":"NF-kappaB activation is required for the transition of pulmonary inflammation to muscle atrophy"},{"title3":"Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease"},{"title3":"Definition and classification of cancer cachexia: an international consensus"},{"title3":"Adipose tissue pathways involved in weight loss of cancer cachexia"},{"title3":"Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease"},{"title3":"Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease"},{"title3":"A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis"},{"title3":"Transdifferentiation properties of adipocytes in the adipose organ"},{"title3":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia"},{"title3":"Brown adipose tissue in morbidly obese subjects"},{"title3":"Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans"},{"title3":"A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans"},{"title3":"Identification and importance of brown adipose tissue in adult humans"},{"title3":"Brown adipose tissue in cancer patients: possible cause of cancer-induced cachexia"},{"title3":"The relationship between brown adipose tissue activity and neoplastic status: an (18)F-FDG PET/CT study in the tropics"},{"title3":"Explained variance for blood gases in a population with COPD"},{"title3":"Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia"},{"title3":"Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia"},{"title3":"Dichotomous effects of VEGF-A on adipose tissue dysfunction"},{"title3":"Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance"},{"title3":"Increased postabsorptive and exercise-induced whole-body glucose production in patients with chronic obstructive pulmonary disease"},{"title3":"Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema"},{"title3":"Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease"},{"title3":"Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes"},{"title3":"Browning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure"},{"title3":"Functional brown adipose tissue in healthy adults"},{"title3":"Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol"},{"title3":"The nutritional status in advanced emphysema associated with chronic bronchitis. A study of amino acid and catecholamine levels"},{"title3":"beta-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease"},{"title3":"Systemic beta-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans"},{"title3":"Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans"},{"title3":"Nutritional status and disease severity in patients with chronic obstructive pulmonary disease (COPD)"},{"title3":"Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: the effect of physical activity and oral nutritional supplementation"},{"title3":"Energy balance in chronic obstructive pulmonary disease"},{"title3":"Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease"},{"title3":"ABC of palliative care. Anorexia, cachexia, and nutrition"},{"title3":"Nicotine administration in healthy non-smokers reduces appetite but does not alter plasma ghrelin"},{"title3":"Symptom burden in stable COPD patients with moderate or severe airflow limitation"},{"title3":"Impact of symptoms of anxiety and depression on COPD Assessment Test scores"},{"title3":"Dietary problems in patients with severe chronic obstructive pulmonary disease"},{"title3":"Weight change and lung cancer: relationships with symptom distress, functional status, and smoking"},{"title3":"The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study"},{"title3":"Prevalence and characteristics of pain in patients with chronic obstructive pulmonary disease compared to the Norwegian general population"},{"title3":"Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study"},{"title3":"Opioid-induced bowel dysfunction"},{"title3":"Principles of opioid use in cancer pain"},{"title3":"Diagnostic approach to chronic constipation in adults"},{"title3":"Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional population based study in The Netherlands"},{"title3":"Identification of human gustatory cortex by activation likelihood estimation"},{"title3":"Gustatory and reward brain circuits in the control of food intake"},{"title3":"Nutrition impact symptoms and body composition in patients with COPD"},{"title3":"Smell and taste function in subjects with chronic obstructive pulmonary disease. Effect of long-term oxygen via nasal cannulas"},{"title3":"Effects of age, gender and chronic obstructive pulmonary disease on taste acuity"},{"title3":"Review article: the role of gastric motility in the control of food intake"},{"title3":"The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC)"},{"title3":"Elevated serum leptin levels: a risk factor for non-small-cell lung cancer?"},{"title3":"Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease"},{"title3":"Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients"},{"title3":"Processing of primary and secondary rewards: a quantitative meta-analysis and review of human functional neuroimaging studies"},{"title3":"fMRI reactivity to high-calorie food pictures predicts short- and long-term outcome in a weight-loss program"},{"title3":"Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome"},{"title3":"Neuropeptide Y and agouti-related peptide mediate complementary functions of hyperphagia and reduced energy expenditure in leptin receptor deficiency"},{"title3":"Metabolic status regulates ghrelin function on energy homeostasis"},{"title3":"Brain activity correlated with food preferences: a functional study comparing advanced non-small cell lung cancer patients with and without anorexia"},{"title3":"Influence of starvation on enzyme-induced emphysema"},{"title3":"Effects of starvation on lung mechanics and biochemistry in young and old rats"},{"title3":"Effects of starvation and refeeding on elastase-induced emphysema"},{"title3":"Effect of severe calorie restriction on the lung in two strains of mice"},{"title3":"Early emphysema in patients with anorexia nervosa"},{"title3":"Diaphragm and body weight in emphysema"},{"title3":"Effect of acute starvation on rat diaphragm function"},{"title3":"The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease"},{"title3":"Dietary counselling and food fortification in stable COPD: a randomised trial"},{"title3":"Casein protein results in higher prandial and exercise induced whole body protein anabolism than whey protein in chronic obstructive pulmonary disease"},{"title3":"Enhanced anabolic response to milk protein sip feeding in elderly subjects with COPD is associated with a reduced splanchnic extraction of multiple amino acids"},{"title3":"Quality of dietary intake in relation to body composition in patients with chronic obstructive pulmonary disease eligible for pulmonary rehabilitation"},{"title3":"Disturbed intestinal integrity in patients with COPD: effects of activities of daily living"},{"title3":"Altered interorgan response to feeding in patients with chronic obstructive pulmonary disease"},{"title3":"Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease"},{"title3":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach"},{"title3":"Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor"},{"title3":"Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment"},{"title3":"Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials"},{"title3":"Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome"},{"title3":"Obesity and the brain: how convincing is the addiction model?"},{"title3":"Youth at risk for obesity show greater activation of striatal and somatosensory regions to food"},{"title3":"Early associations with food in anorexia nervosa patients and obese people assessed in the affective priming paradigm"},{"title3":"Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial"},{"title3":"Pilot randomized trial demonstrating reversal of obesity-related abnormalities in reward system responsivity to food cues with a behavioral intervention"}]},{"title2":"Signaling network of lipids as a comprehensive scaffold for omics data integration in sputum of COPD patients","References":[]},{"title2":"Lipid metabolism in chronic obstructive pulmonary disease","References":[{"title3":"The Global Epidemic of the Metabolic Syndrome"},{"title3":"Burden of metabolic syndrome among primary care patients in Crete, Greece: A descriptive study"},{"title3":"Prevalence of the Metabolic Syndrome and its determinants among Nepalese adults: Findings from a nationally representative cross-sectional study"},{"title3":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases"},{"title3":"Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: A population-based observational study"},{"title3":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes"},{"title3":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups"},{"title3":"Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation"},{"title3":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection"},{"title3":"Nonalcoholic fatty liver disease in lean individuals in the United States"},{"title3":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes"},{"title3":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions"},{"title3":"A position statement on NAFLD/NASH based on the EASL 2009 special conference"},{"title3":"Prevalence of and risk factors for hepatic steatosis in Northern Italy"},{"title3":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement"},{"title3":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease"},{"title3":"Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease"},{"title3":"Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease"},{"title3":"Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease"},{"title3":"Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study"},{"title3":"Relationship between non-alcoholic fatty liver disease and pulmonary function"},{"title3":"Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?"},{"title3":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment"},{"title3":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis"},{"title3":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis"},{"title3":"Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications"},{"title3":"Nonalcoholic fatty liver disease and cardiovascular risk"},{"title3":"NAFLD and cardiovascular diseases: A clinical review"},{"title3":"Comorbidities and Metabolic Derangement of NAFLD"},{"title3":"NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome"},{"title3":"Inflammatory mechanisms in the regulation of insulin resistance"},{"title3":"Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments"},{"title3":"Nonalcoholic fatty liver disease: Pathology and pathogenesis"},{"title3":"Non-Alcoholic Fatty Liver Disease in Non-Obese Individuals: Prevalence, Pathogenesis and Treatment"},{"title3":"Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign"},{"title3":"Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study"},{"title3":"Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives"},{"title3":"Role of cytokines and chemokines in non-alcoholic fatty liver disease"},{"title3":"Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community"},{"title3":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease"},{"title3":"Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation"},{"title3":"Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis"},{"title3":"A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial"},{"title3":"New trends on obesity and NAFLD in Asia"},{"title3":"Diabetes in Asia: Epidemiology, risk factors, and pathophysiology"},{"title3":"Epidemiology of Hepatitis B Virus Infection in Bangladesh: Prevalence among General Population, Risk Groups and Genotype Distribution"},{"title3":"Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia"},{"title3":"Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease"},{"title3":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: Evidence from the Kangbuk Samsung Health Study"},{"title3":"Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study"},{"title3":"Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease"},{"title3":"Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders"},{"title3":"Non-alcoholic fatty liver disease: The problems we are facing"},{"title3":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis"},{"title3":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis"},{"title3":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)"},{"title3":"Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease"},{"title3":"Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD"},{"title3":"Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease"},{"title3":"Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes"},{"title3":"The surface of lipid droplets is a phospholipid monolayer with a unique Fatty Acid composition"},{"title3":"Lipid droplets and liver disease: From basic biology to clinical implications"},{"title3":"Analysis of lipid droplets in hepatocytes"},{"title3":"Lipid Droplets in Health and Disease"},{"title3":"Lipid droplets finally get a little R-E-S-P-E-C-T"},{"title3":"Recent advances in understanding proteins involved in lipid droplet formation, growth and fusion"},{"title3":"Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD"},{"title3":"Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes"},{"title3":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver"},{"title3":"Good fat/bad fat"},{"title3":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity"},{"title3":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis"},{"title3":"Lipotoxicity in nonalcoholic fatty liver disease: Not all lipids are created equal"},{"title3":"Understanding lipotoxicity in NAFLD pathogenesis: Is CD36 a key driver?"},{"title3":"Association between serum free fatty acid levels and nonalcoholic fatty liver disease: A cross-sectional study"},{"title3":"Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load"},{"title3":"Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: Role of stearoyl-CoA desaturase"},{"title3":"Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization"},{"title3":"High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet"},{"title3":"Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism"},{"title3":"Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids"},{"title3":"Obesity and free fatty acids"},{"title3":"TLR4 links innate immunity and fatty acid-induced insulin resistance"},{"title3":"Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid"},{"title3":"The effect of palmitic acid on inflammatory response in macrophages: An overview of molecular mechanisms"},{"title3":"Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways"},{"title3":"Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment"},{"title3":"Hepatic Fibrosis Assessed Using Fibrosis-4 Index Is Predictive of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease"},{"title3":"Anti-NASH Drug Development Hitches a Lift on PPAR Agonism"},{"title3":"Targeting nuclear receptors for the treatment of fatty liver disease"},{"title3":"Modulation of PPAR activity via phosphorylation"},{"title3":"PPARs: Fatty acid sensors controlling metabolism"},{"title3":"Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review"},{"title3":"A lipidomic analysis of nonalcoholic fatty liver disease"},{"title3":"The plasma lipidomic signature of nonalcoholic steatohepatitis"},{"title3":"The Role of Cholesterol in the Pathogenesis of NASH"},{"title3":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH"},{"title3":"Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent"},{"title3":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis"},{"title3":"A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells"},{"title3":"Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice"},{"title3":"Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives"},{"title3":"Mechanisms and regulation of cholesterol homeostasis"},{"title3":"Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases"},{"title3":"Cholesterol 7alpha-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis"},{"title3":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease"},{"title3":"Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects"},{"title3":"LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2"},{"title3":"A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis"},{"title3":"Expression of LXR-beta, ABCA1 and ABCG1 in human triple-negative breast cancer tissues"},{"title3":"Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease"},{"title3":"ABCA1 and atherosclerosis"},{"title3":"ABCA1 and biogenesis of HDL"},{"title3":"Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation"},{"title3":"Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells"},{"title3":"Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease"},{"title3":"Liver X receptors in lipid signalling and membrane homeostasis"},{"title3":"Liver X receptors (LXR) as therapeutic targets in dyslipidemia"},{"title3":"Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine"},{"title3":"Atherosclerosis: Lessons from LXR and the intestine"},{"title3":"Emerging role of liver X receptors in cardiac pathophysiology and heart failure"},{"title3":"Functional interplay between liver X receptor and AMP-activated protein kinase alpha inhibits atherosclerosis in apolipoprotein E-deficient mice:A new anti-atherogenic strategy"},{"title3":"Disrupting LXRalpha phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation"},{"title3":"The innate immune response under the control of the LXR pathway"},{"title3":"LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer"},{"title3":"Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: Liver-X-receptor-specific inhibition of inflammation and primary cytokine production"},{"title3":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta"},{"title3":"Rational application of macrophage-specific LXR agonists avoids the pitfalls of SREBP-induced lipogenesis"},{"title3":"LXR/RXR ligand activation enhances basolateral efflux of beta-sitosterol in CaCo-2 cells"},{"title3":"The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism"},{"title3":"Regulation of the expression of key genes involved in HDL metabolism by unsaturated fatty acids"},{"title3":"Liver X receptors in lipid metabolism: Opportunities for drug discovery"},{"title3":"Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL/6 female mice"},{"title3":"The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD"},{"title3":"Role of LXRs in control of lipogenesis"},{"title3":"Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease"},{"title3":"The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR"},{"title3":"The significance and effects of liver X receptor alpha in nonalcoholic fatty liver disease in rats"},{"title3":"LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling"},{"title3":"Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease"},{"title3":"Principles of bioactive lipid signalling: Lessons from sphingolipids"},{"title3":"Different effects of long- and short-chain ceramides on the gel-fluid and lamellar-hexagonal transitions of phospholipids: A calorimetric, NMR, and x-ray diffraction study"},{"title3":"Molecular associations and surface-active properties of short- and long-N-acyl chain ceramides"},{"title3":"Permeability and microstructure of model stratum corneum lipid membranes containing ceramides with long (C16) and very long (C24) acyl chains"},{"title3":"Biophysics (and sociology) of ceramides"},{"title3":"Ceramide-enriched membrane domains--structure and function"},{"title3":"Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): Implications for lipid raft structure and function"},{"title3":"Ceramide-rich platforms in transmembrane signaling"},{"title3":"Mitochondrial ceramide and the induction of apoptosis"},{"title3":"Plasma Ceramides"},{"title3":"The ceramide ratio: A predictor of cardiometabolic risk"},{"title3":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients"},{"title3":"Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans"},{"title3":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance"},{"title3":"Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet"},{"title3":"Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans"},{"title3":"Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?"},{"title3":"Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis"},{"title3":"Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion"},{"title3":"Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes"},{"title3":"Role of ceramides in nonalcoholic fatty liver disease"},{"title3":"Metabolic Messengers: Ceramides"},{"title3":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis"},{"title3":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice"},{"title3":"CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane"},{"title3":"The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL"},{"title3":"An overview of sphingolipid metabolism: From synthesis to breakdown"},{"title3":"Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: Reversal and improvement of glucose tolerance by lipid metabolism inhibitors"},{"title3":"Ceramide down-regulates System A amino acid transport and protein synthesis in rat skeletal muscle cells"},{"title3":"Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6"},{"title3":"Ceramide starves cells to death by downregulating nutrient transporter proteins"},{"title3":"Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain"},{"title3":"Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide"},{"title3":"Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate"},{"title3":"New insights on the role of ceramide 1-phosphate in inflammation"},{"title3":"The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer"},{"title3":"Ceramides in insulin resistance and lipotoxicity"},{"title3":"Alveolar lipids in pulmonary disease. A review"},{"title3":"Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice"},{"title3":"Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD)"},{"title3":"Cigarette smoke exposure and alveolar macrophages: Mechanisms for lung disease"},{"title3":"Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care"},{"title3":"Chronic obstructive pulmonary disease and phenotypes: A state-of-the-art"},{"title3":"Understanding COPD: A vision on phenotypes, comorbidities and treatment approach"},{"title3":"Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat"},{"title3":"Chronic obstructive pulmonary disease: A definition and implications of structural determinants of airflow obstruction for epidemiology"},{"title3":"Body mass index in male patients with COPD: Correlation with low attenuation areas on CT"},{"title3":"Early emphysema in patients with anorexia nervosa"},{"title3":"It's more than low BMI: Prevalence of cachexia and associated mortality in COPD"},{"title3":"Challenging the obesity paradox: Extreme obesity and COPD mortality in the SUMMIT trial"},{"title3":"Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan"},{"title3":"Diabetes, impaired glucose tolerance, and metabolic biomarkers in individuals with normal glucose tolerance are inversely associated with lung function: The Jackson Heart Study"},{"title3":"Metabolic profiling detects biomarkers of protein degradation in COPD patients"},{"title3":"Association between glycemic state and lung function: The Framingham Heart Study"},{"title3":"Lung function and glucose metabolism: An analysis of data from the Third National Health and Nutrition Examination Survey"},{"title3":"Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: The Fremantle Diabetes Study"},{"title3":"The relationship between low vital capacity and impaired glucose metabolism in men"},{"title3":"Systematic review of the association between lung function and Type 2 diabetes mellitus"},{"title3":"Pulmonary function in diabetes: A metaanalysis"},{"title3":"Low lung function and risk of type 2 diabetes in Japanese men: The Toranomon Hospital Health Management Center Study 9 (TOPICS 9)"},{"title3":"Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men"},{"title3":"Risk of developing diabetes is inversely related to lung function: A population-based cohort study"},{"title3":"Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women"},{"title3":"Cross-sectional and prospective study of lung function in adults with type 2 diabetes: The Atherosclerosis Risk in Communities (ARIC) study"},{"title3":"Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: Possible associations with inflammation"},{"title3":"Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins"},{"title3":"Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes"},{"title3":"ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung"},{"title3":"A critical role for ABCG1 in macrophage inflammation and lung homeostasis"},{"title3":"Loss of ABCG1 results in chronic pulmonary inflammation"},{"title3":"Pulmonary abnormalities due to ABCA1 deficiency in mice"},{"title3":"Lipid and smoker's inclusions in sputum macrophages in patients with airway diseases"},{"title3":"Cut-off values and significance of Oil Red O-positive cells in bronchoalveolar lavage fluid"},{"title3":"Sphingolipids in COPD"},{"title3":"Ceramide expression and cell homeostasis in chronic obstructive pulmonary disease"},{"title3":"Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death"},{"title3":"Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice"},{"title3":"The involvement of sphingolipids in chronic obstructive pulmonary diseases"},{"title3":"Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes"},{"title3":"Structural and functional characterization of endothelial microparticles released by cigarette smoke"},{"title3":"Bioactive Sphingolipids in the Pathogenesis of Chronic Obstructive Pulmonary Disease"},{"title3":"Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression"},{"title3":"Microparticles as potential biomarkers of cardiovascular disease"},{"title3":"Leukocyte-derived microparticles in vascular homeostasis"},{"title3":"Extracellular vesicles: Novel communicators in lung diseases"},{"title3":"Endothelial Cell Morphology Regulates Inflammatory Cells Through MicroRNA Transferred by Extracellular Vesicles"},{"title3":"Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages"},{"title3":"Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011)"},{"title3":"Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease"},{"title3":"Role of liver X receptors in cholesterol efflux and inflammatory signaling (review)"},{"title3":"The role of the liver X receptor in chronic obstructive pulmonary disease"},{"title3":"Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease"},{"title3":"Increase of 27-hydroxycholesterol in the airways of patients with COPD: Possible role of 27-hydroxycholesterol in tissue fibrosis"},{"title3":"Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity"},{"title3":"Orphan nuclear receptors: From gene to function"},{"title3":"Nuclear receptors in macrophage biology: At the crossroads of lipid metabolism and inflammation"},{"title3":"Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications--a review"},{"title3":"Down-regulated peroxisome proliferator-activated receptor gamma (PPARgamma) in lung epithelial cells promotes a PPARgamma agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD)"},{"title3":"Agonistic induction of PPARgamma reverses cigarette smoke-induced emphysema"},{"title3":"Airway epithelial cell PPARgamma modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice"},{"title3":"Peroxisome proliferator-activated receptors: A therapeutic target in COPD?"},{"title3":"Impacts of peroxisome proliferator-activated receptor-gamma activation on cigarette smoke-induced exacerbated response to bacteria"},{"title3":"PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway"},{"title3":"Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARgamma/LXRalpha pathway: Findings from in vitro and ex vivo studies"},{"title3":"Cigarette smoke affects ABCAl expression via liver X receptor nuclear translocation in human keratinocytes"},{"title3":"Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense"},{"title3":"Liver X receptor agonists inhibit tissue factor expression in macrophages"},{"title3":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors"},{"title3":"Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses"},{"title3":"Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologic studies"},{"title3":"Reduction in plasma free fatty acid in patients with chronic obstructive pulmonary disease"},{"title3":"Genetic Control of Fatty Acid beta-Oxidation in Chronic Obstructive Pulmonary Disease"},{"title3":"Saturated Fat Intake Is Associated with Lung Function in Individuals with Airflow Obstruction: Results from NHANES 2007-2012"},{"title3":"Elevated CO"},{"title3":"Cigarette Smoke Reduces Fatty Acid Catabolism, Leading to Apoptosis in Lung Endothelial Cells: Implication for Pathogenesis of COPD"},{"title3":"Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls"},{"title3":"Dietary omega-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD"},{"title3":"Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets"},{"title3":"Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease"},{"title3":"Inflammation and immune response in COPD: Where do we stand?"},{"title3":"The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling"},{"title3":"The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study"},{"title3":"Adiponectin:A key adipokine in the metabolic syndrome"},{"title3":"Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease"},{"title3":"Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds"},{"title3":"Systemic inflammation in patients of chronic obstructive pulmonary disease with metabolic syndrome"},{"title3":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation"},{"title3":"Role of the HIF-1 signaling pathway in chronic obstructive pulmonary disease"},{"title3":"Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease"},{"title3":"Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis"},{"title3":"HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling"},{"title3":"Hypoxia-inducible factor 2alpha drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein"},{"title3":"Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2alpha/PPARalpha pathway"},{"title3":"Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway"},{"title3":"Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease"},{"title3":"Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target"},{"title3":"Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1"},{"title3":"Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression"},{"title3":"Endothelial HIF-2alpha as a Key Endogenous Mediator Preventing Emphysema"},{"title3":"Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD"}]},{"title2":"Alterations in serum polyunsaturated fatty acids and eicosanoids in patients with mild to moderate chronic obstructive pulmonary disease (COPD)","References":[{"title3":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary"},{"title3":"Epidemiology and prevalence of chronic obstructive pulmonary disease"},{"title3":"The 10 Leading Causes of Death in the World, 2000 and 2012"},{"title3":"Effects of cigarette smoking on lung function in adolescent boys and girls"},{"title3":"Sex differences in lung vulnerability to tobacco smoking"},{"title3":"Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project"},{"title3":"Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team"},{"title3":"Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects"},{"title3":"Cigarette smoking, cardiovascular disease, and stroke a statement for healthcare professionals from the American Heart Association"},{"title3":"Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1,937,360 people in England: Lifetime risks and implications for risk prediction"},{"title3":"Cardiovascular disease in COPD: Mechanisms"},{"title3":"Systems biology research into cardiovascular Disease: Contributions of lipidomics-based approaches to biomarker discovery"},{"title3":"Smoking and cardiovascular disease mechanisms of endothelial dysfunction and early atherogenesis"},{"title3":"Docosahexaenoic acid and smoking-related chronic obstructive pulmonary disease"},{"title3":"Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease"},{"title3":"Relation of smoking and alcohol consumption to serum fatty acids"},{"title3":"Lipidomic changes in rat liver after long-term exposure to ethanol"},{"title3":"Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1"},{"title3":"Advances in mass spectrometry for lipidomics"},{"title3":"Metabolic profiling reveals distinct variations linked to nicotine consumption in humans:First results from the KORA study"},{"title3":"Plasma lipid profiling in a large population-based cohort"},{"title3":"Metabolomics using GC-TOF-MS followed by subsequent GC-FID and HILIC-MS/MS analysis revealed significantly altered fatty acid and phospholipid species profiles in plasma of smokers"},{"title3":"Metabolic profiling detects biomarkers of protein degradation in COPD patients"},{"title3":"Identification of gene expression signature for cigarette smoke exposure response:From man to mouse"},{"title3":"Physiological measures in subjects with mild to moderate COPD compared to asymptomatic current smokers, former smokers and never-smokers"},{"title3":"Systems toxicology approach to evaluate the impact of smoking and chronic obstructive pulmonary disease on the nasal epithelium"},{"title3":"Lipidomics reveals a remarkable diversity of lipids in human plasma"},{"title3":"Regularization paths for generalized linear models via coordinate descent"},{"title3":"WGCNA: An R package for weighted correlation network analysis"},{"title3":"A review of the new HGNC gene family resource"},{"title3":"Acute phase proteins"},{"title3":"Cellular response to cigarette smoke and oxidants: Adapting to survive"},{"title3":"Lipid mediator profiling in pulmonary disease"},{"title3":"Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids"},{"title3":"Effects of cigarette smoke, cessation and switching to two heat-not-burn tobacco products on lung lipid metabolism in C57BL/6 and Apoe-/- mice:An integrative systems toxicology analysis"},{"title3":"Effects of smoking and smoking cessation on human serum metabolite profile: Results from the KORA cohort study"},{"title3":"Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)"},{"title3":"Serum metabolite biomarkers discriminate healthy smokers from COPD smokers"},{"title3":"Cigarette smoking and serum lipid and lipoprotein concentrations: An analysis of published data"},{"title3":"Smoking and smoking cessation:The relationship between cardiovascular disease and lipoprotein metabolism: A review"},{"title3":"omega-3 Polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?"},{"title3":"Edinburgh artery study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population"},{"title3":"Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study"},{"title3":"The relationship between omega-3 and smoking habit: A cross-sectional study"},{"title3":"omega-3 Polyunsaturated fatty acids and chronic obstructive pulmonary disease"},{"title3":"Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993"},{"title3":"Plan and operation of the NHANES I Epidemiologic Followup Study, 1987"},{"title3":"Role of polyunsaturated fatty acids in lung disease"},{"title3":"Dietary intake of isoflavones and polyunsaturated fatty acids associated with lung function, breathlessness and the prevalence of chronic obstructive pulmonary disease: Possible protective effect of traditional Japanese diet"},{"title3":"Dietary and supplemental antioxidant and anti-inflammatory nutrient intakes and pulmonary function"},{"title3":"Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: A systematic review"},{"title3":"The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive pulmonary disease: A systematic review"},{"title3":"Plasmalogens the neglected regulatory and scavenging lipid species"},{"title3":"Peroxyl radicals: Inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products"},{"title3":"Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma"},{"title3":"Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments"},{"title3":"Oxidative stress in COPD"},{"title3":"Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages"},{"title3":"Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice"},{"title3":"Systemic effects of smoking"},{"title3":"Oxidative stress, respiratory muscle dysfunction, and potential therapeutics in chronic obstructive pulmonary disease"},{"title3":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid"},{"title3":"Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall"},{"title3":"12/15-Lipoxygenase mediates high-fat diet-induced endothelial tight junction disruption and monocyte transmigration: A new role for 15 (S)-hydroxyeicosatetraenoic acid in endothelial cell dysfunction"},{"title3":"15-Hydroxyeicosatetraenoic acid inhibits phorbol-12-myristate-13-acetate-induced MUC5AC expression in NCI-H292 respiratory epithelial cells"},{"title3":"Action of epoxyeicosatrienoic acids on cellular function"},{"title3":"Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells: Implications for the vascular effects of soluble epoxide hydrolase inhibition"},{"title3":"Dihydroxyeicosatrienoic acids are potent activators of Ca2+-activated K+ channels in isolated rat coronary arterial myocytes"},{"title3":"Epoxyeicosatrienoic acids and/or their metabolites promote hypoxic response of cells"},{"title3":"14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha"},{"title3":"In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor"},{"title3":"Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor"},{"title3":"The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation"},{"title3":"Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo"},{"title3":"Detection of lipid peroxidation in vivo: Total hydroxyoctadecadienoic acid and 7-hydroxycholesterol as oxidative stress marker"},{"title3":"Relative potencies of statins in reducing cholesterol synthesis and enhancing linoleic acid metabolism"},{"title3":"Effects of diet and simvastatin on fatty acid composition in hypercholesterolemic men: A randomized controlled trial"},{"title3":"Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points:A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine"},{"title3":"Nonfasting for routine lipid testing: From evidence to action"},{"title3":"Unraveling Glycerophospholipidomes by Lipidomics"},{"title3":"High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry"},{"title3":"Automated Identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning"},{"title3":"Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer"},{"title3":"Automated quantitative analysis of complex lipidomes by liquid chromatography/mass spectrometry"},{"title3":"Comprehensive systems biology analysis of a 7-month cigarette smoke inhalation study in C57BL/6 mice"},{"title3":"MetaboLights:An open-access general-purpose repository for metabolomics studies and associated meta-data"},{"title3":"R: A Language and Environment for Statistical Computing"},{"title3":"Bioconductor: Open software development for computational biology and bioinformatics"},{"title3":"Building predictive models in R using the caret package"},{"title3":"Evaluation: From precision, recall and F-measure to ROC, informedness, markedness and correlation"},{"title3":"Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods"},{"title3":"Update of the LIPID MAPS comprehensive classification system for lipids"}]},{"title2":"Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease","References":[]},{"title2":"Relation of smoking and alcohol consumption to serum fatty acids","References":[]},{"title2":"Docosahexaenoic acid and smoking-related chronic obstructive pulmonary disease","References":[]},{"title2":"Peroxyl radicals: Inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products","References":[]},{"title2":"Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma","References":[]},{"title2":"Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated dysbiosis","References":[{"title3":"Expression and characterization of the Escherichia coli fdo locus and a possible physiological role for aerobic formate dehydrogenase"},{"title3":"Critical roles of Notch and Wnt/beta-catenin pathways in the regulation of hyperplasia and/or colitis in response to bacterial infection"},{"title3":"Crohn's disease"},{"title3":"Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum"},{"title3":"Structural genes for nitrate-inducible formate dehydrogenase in Escherichia coli K-12"},{"title3":"Rapid development of colitis in NSAID-treated IL-10-deficient mice"},{"title3":"Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis"},{"title3":"The complete genome sequence of Escherichia coli K-12"},{"title3":"Fast and sensitive protein alignment using DIAMOND"},{"title3":"S- and N-Oxide Reductases"},{"title3":"Polysaccharide Degradation by the Intestinal Microbiota and Its Influence on Human Health and Disease"},{"title3":"Respiration of Nitrate and Nitrite"},{"title3":"Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells"},{"title3":"Glycan degradation (GlyDeR) analysis predicts mammalian gut microbiota abundance and host diet-specific adaptations"},{"title3":"Predicting a human gut microbiota's response to diet in gnotobiotic mice"},{"title3":"Eating for two: how metabolism establishes interspecies interactions in the gut"},{"title3":"Microbial degradation of complex carbohydrates in the gut"},{"title3":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases"},{"title3":"The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique"},{"title3":"Compounds which serve as the sole source of carbon or nitrogen for Salmonella typhimurium LT-2"},{"title3":"Complete genome sequence of the extremely acidophilic methanotroph isolate V4, Methylacidiphilum infernorum, a representative of the bacterial phylum Verrucomicrobia"},{"title3":"MEGAN analysis of metagenomic data"},{"title3":"Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function"},{"title3":"How glycan metabolism shapes the human gut microbiota"},{"title3":"The pyruvate formate lyase family: sequences, structures and activation"},{"title3":"Bacterial molybdoenzymes: old enzymes for new purposes"},{"title3":"Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration"},{"title3":"Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae"},{"title3":"Biosynthesis and Insertion of the Molybdenum Cofactor"},{"title3":"The devil lies in the details: how variations in polysaccharide fine-structure impact the physiology and evolution of gut microbes"},{"title3":"Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis"},{"title3":"The pyruvate dehydrogenase complexes: structure-based function and regulation"},{"title3":"Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-gamma-dependent elimination of Paneth cells"},{"title3":"Pyruvate ferredoxin oxidoreductase and its radical intermediate"},{"title3":"Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis"},{"title3":"Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of Salmonella"},{"title3":"Nitrate reductase complex of Escherichia coli K-12: isolation and characterization of mutants unable to reduce nitrate"},{"title3":"A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism"},{"title3":"Anaerobic Formate and Hydrogen Metabolism"},{"title3":"Fermentative Pyruvate and Acetyl-Coenzyme A Metabolism"},{"title3":"Formation of the formate-nitrate electron transport pathway from inactive components in Escherichia coli"},{"title3":"Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon"},{"title3":"Proteobacteria: microbial signature of dysbiosis in gut microbiota"},{"title3":"Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations"},{"title3":"Diet-microbiota interactions as moderators of human metabolism"},{"title3":"Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota"},{"title3":"The formation of hydrogen from glucose and formic acid by the so-called &quot;resting&quot; B. coli. I"},{"title3":"Properties and function of the pyruvate-formate-lyase reaction in clostridiae"},{"title3":"The Aerobic and Anaerobic Respiratory Chain of Escherichia coli and Salmonella enterica: Enzymes and Energetics"},{"title3":"Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism"},{"title3":"Coordinate regulation of the Escherichia coli formate dehydrogenase fdnGHI and fdhF genes in response to nitrate, nitrite, and formate: roles for NarL and NarP"},{"title3":"The dynamics of gut-associated microbial communities during inflammation"},{"title3":"Host-derived nitrate boosts growth of E. coli in the inflamed gut"},{"title3":"Formic acid dehydrogenasecytochrome b1 complex from Escherichia coli"},{"title3":"Linking long-term dietary patterns with gut microbial enterotypes"}]},{"title2":"Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony","References":[{"title3":"Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary"},{"title3":"From COPD to chronic systemic inflammatory syndrome?"},{"title3":"Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care"},{"title3":"The potential impact of anaemia of chronic disease in COPD"},{"title3":"From muscle disuse to myopathy in COPD: potential contribution of oxidative stress"},{"title3":"COPD, bone metabolism, and osteoporosis"},{"title3":"COPD prevalence is increased in lung cancer, independent of age, sex and smoking history"},{"title3":"Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee"},{"title3":"Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study"},{"title3":"Cardiovascular and metabolic influences of fetal smoke exposure"},{"title3":"Cigarette smoking and the risk of diabetes in women"},{"title3":"Systemic effects of smoking"},{"title3":"Type 1 diabetes: etiology, immunology, and therapeutic strategies"},{"title3":"Banting Memorial Lecture 2010^. Type 2 diabetes as an 'infectious' disease: is this the Black Death of the 21st century?"},{"title3":"Association between chronic obstructive pulmonary diseases and diabetes mellitus, type I and II"},{"title3":"Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD"},{"title3":"Prevalence of comorbidities in patients with chronic obstructive pulmonary disease"},{"title3":"Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals"},{"title3":"Comorbidities of chronic obstructive pulmonary disease in koreans: a population-based study"},{"title3":"Harmonizing the Metabolic Syndrome: a Joint Interim Statement of the Association for the Study of Obesity Heart Federation; International Atherosclerosis Society; and International National Heart, Lung, and Blood Institute; American Heart Association; World International Diabetes Federation Task Force on Epidemiology and Prevention"},{"title3":"Respiratory function in an obese patient with sleep-disordered breathing"},{"title3":"Obesity and lung inflammation"},{"title3":"Lung function impairment and metabolic syndrome: the critical role of abdominal obesity"},{"title3":"Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study"},{"title3":"Association between low pulmonary function and metabolic risk factors in Korean adults: the Korean National Health and Nutrition Survey"},{"title3":"The metabolic syndrome in patients with chronic obstructive pulmonary disease"},{"title3":"COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care"},{"title3":"Body composition and functional limitation in COPD"},{"title3":"The relation of body mass index to asthma, chronic bronchitis, and emphysema"},{"title3":"Body mass index and the risk of COPD"},{"title3":"Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study"},{"title3":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease"},{"title3":"Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire"},{"title3":"Muscle wasting in chronic obstructive pulmonary disease: to bother and to measure!"},{"title3":"Prognostic value of nutritional status in chronic obstructive pulmonary disease"},{"title3":"Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study"},{"title3":"Body-mass index and mortality in Korean men and women"},{"title3":"Central insulin and leptin-mediated autonomic control of glucose homeostasis"},{"title3":"Effects of leptin and adiponectin on pancreatic beta-cell function"},{"title3":"Leptin as local inflammatory marker in COPD"},{"title3":"Does leptin play a cytokine-like role within the airways of COPD patients?"},{"title3":"Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease"},{"title3":"Circulating leptin in patients with chronic obstructive pulmonary disease"},{"title3":"Circulating leptin and body composition in chronic obstructive pulmonary disease"},{"title3":"Serum resistin and leptin in patients with chronic obstructive pulmonary disease and their relationship to nutritional state"},{"title3":"Putative roles of circulating resistin in patients with asthma, COPD and cigarette smokers"},{"title3":"Leptin receptor polymorphisms and lung function decline in COPD"},{"title3":"Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters"},{"title3":"Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease"},{"title3":"The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation"},{"title3":"Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease"},{"title3":"The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients"},{"title3":"Elevated circulating plasma adiponectin in underweight patients with COPD"},{"title3":"Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease"},{"title3":"Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease"},{"title3":"Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice"},{"title3":"The complex relationship of serum adiponectin to COPD outcomes"},{"title3":"Dysregulated adipokine metabolism in chronic obstructive pulmonary disease"},{"title3":"Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes"},{"title3":"Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease"},{"title3":"Regulation of oxygen homeostasis by hypoxia-inducible factor 1"},{"title3":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus"},{"title3":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study"},{"title3":"Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus"},{"title3":"Inflammatory markers and risk of developing type 2 diabetes in women"},{"title3":"Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study"},{"title3":"IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice"},{"title3":"Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease"},{"title3":"Associations of IL6 polymorphisms with lung function decline and COPD"},{"title3":"Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease"},{"title3":"IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study"},{"title3":"Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease"},{"title3":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis"},{"title3":"High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes"},{"title3":"C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease"},{"title3":"Genetic determinants of C-reactive protein in COPD"},{"title3":"C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease"},{"title3":"Hypoxic damage to pancreatic beta cells-the hidden link between sleep apnea and diabetes"},{"title3":"The effects of adenosine, exercise, and acute moderate hypoxia on energy substrate utilization of human skeletal muscle"},{"title3":"The effect of hypoxia and work intensity on insulin resistance in type 2 diabetes"},{"title3":"Oxygen supplementation increases glucose tolerance during euglycaemic hyperinsulinaemic glucose clamp procedure in patients with severe COPD and chronic hypoxaemia"},{"title3":"Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression"},{"title3":"Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets"},{"title3":"Hypoxia causes glucose intolerance in humans"},{"title3":"Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes"},{"title3":"Hypoxia decreases insulin signaling pathways in adipocytes"},{"title3":"Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue"},{"title3":"Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function"},{"title3":"Skeletal muscle &quot;mitochondrial deficiency&quot; does not mediate insulin resistance"},{"title3":"Stimulation of glucose transport in skeletal muscle by hypoxia"},{"title3":"Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease"},{"title3":"Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure"},{"title3":"Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease"},{"title3":"Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease"},{"title3":"Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease"},{"title3":"Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis"},{"title3":"Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease"},{"title3":"Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease"},{"title3":"Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged &gt;or=70 years"},{"title3":"Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome"},{"title3":"Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromso study"},{"title3":"Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life"},{"title3":"Testosterone deficiency"},{"title3":"Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease"},{"title3":"Hypothalamic-pituitary dysfunction in respiratory hypoxia"},{"title3":"Glucose metabolism and catecholamines"},{"title3":"Blood pressure and plasma catecholamines in acute and prolonged hypoxia: effects of local hypothermia"},{"title3":"Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease"},{"title3":"Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment"},{"title3":"The renin-angiotensin system: a link between obesity, inflammation and insulin resistance"},{"title3":"Abnormalities of sodium and H2O handling in chronic obstructive lung disease"},{"title3":"Hormonal abnormalities affecting sodium and water balance in acute respiratory failure due to chronic obstructive lung disease"},{"title3":"Hormonal, renal, and autonomic nerve factors involved in the excretion of sodium and water during dynamic salt and water loading in hypoxaemic chronic obstructive pulmonary disease"},{"title3":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease"},{"title3":"Vitamin D, and increasing incidence of type 1 diabetes-evidence for an association?"},{"title3":"Vitamin D and type 2 diabetes: a systematic review"},{"title3":"The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer"},{"title3":"Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease"},{"title3":"Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study"},{"title3":"Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study"},{"title3":"Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation"},{"title3":"Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study"},{"title3":"Baseline forced expiratory volume in the first second as an independent predictor of development of the metabolic syndrome"},{"title3":"Risk of developing diabetes is inversely related to lung function: a population-based cohort study"},{"title3":"Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study"},{"title3":"Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men"},{"title3":"A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population"},{"title3":"The Relationship between Lung Function and Metabolic Syndrome in Obese and Non-Obese Korean Adult Males"},{"title3":"Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males"},{"title3":"Noninvasive assessment of the tension-time index of inspiratory muscles at rest in obese male subjects"},{"title3":"Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: the Strong Heart Study"},{"title3":"Low Lung Function and Risk of Type 2 Diabetes in Japanese Men: The Toranomon Hospital Health Management Center Study 9 (TOPICS 9)"},{"title3":"Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women"},{"title3":"Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study"},{"title3":"Insulin resistance and inflammation - A further systemic complication of COPD"},{"title3":"The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control"},{"title3":"Glucocorticoids"},{"title3":"Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group"},{"title3":"Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD"},{"title3":"Corticosteroids contribute to muscle weakness in chronic airflow obstruction"},{"title3":"Respiratory steroid myopathy"},{"title3":"Inspiratory muscle strength and endurance in steroid-dependent asthma"},{"title3":"The effect of corticosteroids on inspiratory muscle performance in humans"},{"title3":"Systemic effects of inhaled corticosteroids"},{"title3":"Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids"},{"title3":"The association of inhaled corticosteroid use with serum glucose concentration in a large cohort"},{"title3":"Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus"},{"title3":"Vascular memory: can we broaden the concept of the metabolic memory?"},{"title3":"Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect"},{"title3":"Insulin improves alveolar-capillary membrane gas conductance in type 2 diabetes"},{"title3":"The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin"},{"title3":"Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus"},{"title3":"An assessment of eligibility for inhaled insulin (Exubera): the Fremantle Diabetes Study"},{"title3":"The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin"},{"title3":"Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial"},{"title3":"Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial"},{"title3":"Alveolar gas exchange in patients with type 2 diabetes mellitus"},{"title3":"Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy"},{"title3":"Pulmonary gas exchange in life-long nonsmoking patients with diabetes mellitus"},{"title3":"Lung elasticity in juvenile-onset diabetes mellitus"},{"title3":"Demidov IuI [Gas exchange function of the lungs in patients with type 1 diabetes mellitus]"},{"title3":"Characteristics of pulmonary function in patients with diabetes mellitus"},{"title3":"Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus"},{"title3":"Lung function in patients with diabetes mellitus"},{"title3":"Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus"},{"title3":"Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus"},{"title3":"Pulmonary complications of type 1 (insulin-dependent) diabetic patients"},{"title3":"Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus"},{"title3":"Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy"},{"title3":"The assessment of pulmonary diffusing capacity in diabetes mellitus with regard to microalbuminuria"},{"title3":"Impaired diffusing capacity for carbon monoxide in children with type 1 diabetes: is this the first sign of long-term complications?"},{"title3":"Pulmonary functions in patients with type 2 diabetes mellitus &amp; correlation with anthropometry &amp; microvascular complications"},{"title3":"Pulmonary function and circulating adhesion molecules in patients with diabetes mellitus"},{"title3":"Pulmonary function in patients with diabetes mellitus"},{"title3":"Motor dysfunction in diabetes"},{"title3":"Impact of diabetes on physical function in older people"},{"title3":"Diaphragm adaptations in patients with COPD"},{"title3":"Phrenic nerve conduction in diabetic patients. A preliminary study"},{"title3":"Phrenic neuropathy in patients with diabetes mellitus"},{"title3":"Phrenic nerve function in type 1 diabetic patients with diaphragm weakness and peripheral neuropathy"},{"title3":"Phrenic neuropathy in association with diabetes"},{"title3":"The impact of insulin-dependent diabetes on ventilatory control in the mouse"},{"title3":"Changes in myosin structure and function in response to glycation"},{"title3":"Inspiratory muscle performance and pulmonary function changes in insulin-dependent diabetes mellitus"},{"title3":"Respiratory failure secondary to diabetic neuropathy affecting the phrenic nerve"},{"title3":"Bilateral phrenic neuropathies in a diabetic patient responsive to intravenous immunoglobulin: a case report"},{"title3":"Proximal diabetic neuropathy presenting with respiratory weakness"},{"title3":"Reduction in lung functions in type-2 diabetes in Indian population: correlation with glycemic status"},{"title3":"Dyspnoea, peripheral airway involvement and respiratory muscle effort in patients with type I diabetes mellitus under good metabolic control"},{"title3":"Respiratory muscle function and hypoxic ventilatory control in patients with type I diabetes"},{"title3":"Hypoxic and hypercapnic breathlessness in patients with type I diabetes mellitus"},{"title3":"Reduced respiratory muscle strength and endurance in type 2 diabetes mellitus"},{"title3":"Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults"},{"title3":"Association between glycemic state and lung function: the Framingham Heart Study"},{"title3":"Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study"},{"title3":"Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study"},{"title3":"Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey"},{"title3":"Lung function in type 2 diabetes: the Normative Aging Study"},{"title3":"Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease"},{"title3":"Increased systemic inflammation is a risk factor for COPD exacerbations"},{"title3":"Impact of exacerbations on COPD"},{"title3":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus"},{"title3":"Factors determining the appearance of glucose in upper and lower respiratory tract secretions"},{"title3":"Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients"},{"title3":"Control of methicillin-resistant Staphylococcus aureus"},{"title3":"The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia"},{"title3":"Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease"},{"title3":"Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD"},{"title3":"Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study"},{"title3":"The impact of insulin sensitisers on lung function in patients with chronic obstructive pulmonary disease and diabetes"},{"title3":"Could oral hypoglycemics be the new therapeutic answer to chronic obstructive pulmonary disease?"},{"title3":"Effects of Exenatide vs. Metformin on Endothelial Function in Obese Patients with Pre-Diabetes: A Randomized Trial"},{"title3":"Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan"},{"title3":"Chronic obstructive pulmonary disease and lung cancer: common pathogenesis, shared clinical challenges"},{"title3":"Metformin prevents tobacco carcinogen-induced lung tumorigenesis"},{"title3":"Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153"},{"title3":"Antiproliferative action of metformin in human lung cancer cell lines"},{"title3":"Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes"},{"title3":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis"},{"title3":"Metformin does not alter the risk of lung cancer: A case-control analysis"},{"title3":"Metformin attenuates ventilator-induced lung injury"},{"title3":"The occurrence of sleep-disordered breathing among middle-aged adults"},{"title3":"Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea"},{"title3":"Sympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children"},{"title3":"Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial"},{"title3":"Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins"},{"title3":"The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus"},{"title3":"Sleep apnea and cardiovascular disease: a bidirectional relationship"},{"title3":"Importance and management of chronic sleep apnoea in cardiology"},{"title3":"Mechanisms of cardiac dysfunction in obstructive sleep apnea"},{"title3":"Obstructive sleep apnea and kidney disease: is there any direct link?"},{"title3":"Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?"},{"title3":"Obstructive sleep apnea syndrome"},{"title3":"Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease"},{"title3":"Reflex effects of upper airway irritation on total lung resistance and blood pressure"},{"title3":"CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD"},{"title3":"Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome"},{"title3":"Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males"},{"title3":"The Effect of Sleep Apnea and Insomnia on Blood Levels of Leptin, Insulin Resistance, IP-10, and Hydrogen Sulfide in Type 2 Diabetic Patients"},{"title3":"High levels of inflammation and insulin resistance in obstructive sleep apnea patients with hypertension"},{"title3":"Obstructive sleep apnea and type 2 diabetes: is there a link?"},{"title3":"Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study"},{"title3":"Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism"},{"title3":"Consequences of Obstructive Sleep Apnea on Metabolic Profile: A Population-Based Survey"},{"title3":"Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status"},{"title3":"Independent Association Between Obstructive Sleep Apnea Severity and Glycated Hemoglobin in Adults Without Diabetes"},{"title3":"Obstructive Sleep Apnea in Young Lean Men: Impact on insulin sensitivity and secretion"},{"title3":"Obstructive sleep apnea as a risk factor for type 2 diabetes"},{"title3":"Sleep apnea and glucose metabolism - a long-term follow-up in a community-based sample"},{"title3":"Obstructive sleep apnoea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies"},{"title3":"CPAP for the metabolic syndrome in patients with obstructive sleep apnea"},{"title3":"A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea"},{"title3":"The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly"},{"title3":"Elevated incidence of sleep apnoea in acromegaly-correlation to disease activity"},{"title3":"Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis"},{"title3":"Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease: Is the Liver Another Target?"},{"title3":"Nonalcoholic fatty liver disease"},{"title3":"Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?"},{"title3":"Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?"}]},{"title2":"Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance study","References":[]},{"title2":"Energy expenditure in women and men with COPD","References":[]},{"title2":"An artificial intelligence approach to early predict symptom-based exacerbations of COPD","References":[]},{"title2":"Feature-weighted survival learning machine for COPD failure prediction","References":[]},{"title2":"Machine learning approaches for predicting disposition of asthma and COPD exacerbations in the ED","References":[]}]},{"title1":"Positive result of Sars?Cov?2 in faeces and sputum from discharged patients with COVID?19 in Yiwu, China","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection","References":[{"title3":"Outbreak of pneumonia of unknown etiology In Wuhan, China: the mystery and the miracle"},{"title3":"Origin and evolution of the 2019 novel coronavirus"},{"title3":"Update: 'A bit chaotic.' Christening of new coronavirus and its disease name create confusion"},{"title3":"General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial 4th ed.) (In Chinese) 2020. https://bgs.satcm.gov.cn/zhengcewenjian/2020-01-28/12576.html. Accessed January 18, 2020."},{"title3":"The severe acute respiratory syndrome coronavirus in tears"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"Dai X. Peking University Hospital Wang Guangfa disclosed treatment status on Weibo and suspected infection without wearing goggles. Beijing News, 24 January 2020. http://www.bjnews.com.cn/news/2020/01/23/678189.html. Accessed January 23, 2020"},{"title3":"2019-nCoV transmission through the ocular surface must not be ignored"},{"title3":"General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial 5th ed.) (In Chinese) 2020. https://bgs.satcm.gov.cn/zhengcewenjian/2020-02-06/12848.html. Accessed February 6, 2020."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections"},{"title3":"Infection control guidelines for optometrists 2016"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A meta-analysis to evaluate the effectiveness of real-time PCR for diagnosing novel coronavirus infections"},{"title3":"Tears and conjunctival scrapings for coronavirus in patients with SARS"}]},{"title2":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Serological evidence of bat SARS-related coronavirus infection in humans, China"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia","References":[{"title3":"A novel coronavirus from patients with pneumoniain China"},{"title3":"  . http://www.nhc.gov.cn/xcs/yqfkdt/202002/945bd98a9d884aeeb54d76afa02ca813.shtml. Accessed on 25 February 2020."},{"title3":"Novel coronavirus(2019-nCoV): situation report-36"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Isolation of 2019-nCoV from a stool specimen of a laboratory-confirmed case of the coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"}]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection"},{"title3":"New coronavirus pneumonia prevention and control program (4th edn)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"The Spanish flu in Iceland 1918. Lessons in medicine and history"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Novel 2019 coronavirus genome"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Rubella and pregnancy: diagnosis, management and outcomes"},{"title3":"Wuhan Tongji Hospital diagnoses first case of neonatal infection with new coronavirus"},{"title3":"Neonatal coronavirus expert confirmed at 30 hours of birth: vertical transmission from mother to infant"}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia","References":[{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"  . China-WHO new coronavirus pneumonia (COVID-19) joint inspection report."},{"title3":"Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China"},{"title3":"  . Diagnosis and treatment plan forpneumonia caused by new coronavirus (fifth edition), Office of State TCM Administration."},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"A novel coronavirus emerging in China - key questions for impact assessment"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"First case of severe childhood novel coronavirus pneumonia in China"},{"title3":"SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics"},{"title3":"A case of neonatal SARS-CoV-2 infection with gastrointestinal symptoms as the first manifestation"},{"title3":"China's first neonatal coronaviruspneumonia"},{"title3":"Clinical and epidemiological characteristicsof 34 children with new coronavirus infection in ShenZhen"},{"title3":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"Chest computed tomography in children with COVID-19 respiratory infection"},{"title3":"First case of 2019 novel coronavirus in the United States"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients","References":[]},{"title2":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin","References":[]},{"title2":"Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process","References":[]},{"title2":"Fecal transmission in COVID-19: a potential shedding route","References":[{"title3":"Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"C.China Medical Treatment Expert Group for Y Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Prolonged presence of SARS-CoV-2 viral RNA in faecal samples"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?"},{"title3":"The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes"},{"title3":"Evidence for gastrointestinal infection of SARS-CoV-2"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"}]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Positive RT-PCR Test Results in Patients Recovered From COVID-19 [published online ahead of print, 2020 Feb 27]","References":[{"title3":"Positive RT-PCR Test Results in Patients Recovered From COVID-19"},{"title3":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan"},{"title3":"Cause analysis and treatment strategies of recurrent positive nucleic acid test with Coronavirus disease 2019 (COVID-19) patients after discharge from hospital"},{"title3":"Efficacy of acupuncture at three nasal acupoints plus acupoint application for perennial allergic rhinitis: A multicenter, randomized controlled trial protocol"},{"title3":"To discuss the TCM prevention and treatment strategies of Coronavirus disease 2019 from the perspective of Cold-dampness plague"},{"title3":"Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: A Randomized Clinical Trial"},{"title3":"Effect of hot arm and foot bath on heart rate variability and blood pressure in healthy volunteers"},{"title3":"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis"},{"title3":"Two Cases of Improving Positive results of nucleic acid test in Coronavirus disease 2019 (COVID-19) by induced sputum with atomization inhalation"},{"title3":"The effect of Baduanjin exercise on health-related physical fitness of college students: study protocol for a randomized controlled trial"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A Review Study on the Beneficial Effects of Baduanjin"}]},{"title2":"The 31st press conference on epidemic prevention and control from Guangdong Provincial Government Information Office","References":[]},{"title2":"Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections","References":[]},{"title2":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province","References":[{"title3":"Novel Coronavirus (2019-nCoV)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A cumulative number of 549 novel coronavirus cases was reported in Hubei province"},{"title3":"Coronavirus pathogenesis"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Infectious diseases. Battling SARS on the frontlines"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"MERS, SARS, and Ebola: The role of super-spreaders in infectious disease"},{"title3":"SARS: clinical features and diagnosis"},{"title3":"Fever and coughing are not the only first symptoms in patients with novel coronavirus pneumonia (2019-nCoV)"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Analysis of glucocorticoid treatment in 453 cases of infectious atypical pneumonia (in Chinese)"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"Clinical issues and research in respiratory failure from severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"}]}]}]}